







Title of Dissertation: THE EFFECT OF FEEDING MIXED 
TOCOPHEROL OIL ON BODY 
ACCUMULATION AND IMMUNE CELL 
FUNCTIONS IN LACTATING HOLSTEIN 
DAIRY COWS   
  
 
Yang Qu, Doctor of Philosophy, 2017 
  
Dissertation directed by: Assistant Professor Kasey M. Moyes, 
Department of Animal and Avian Sciences 
Non-α-tocopherol (i.e. β, γ, and δ-tocopherol) supplements are as important as α-
tocopherol with regard to maintain lactating dairy cow health.  However, information on 
non-α-tocopherol bioaccumulation and its effects on immune cell function is not 
available.  A series of experiments were conducted to investigate the effect of mixed 
tocopherol oil supplement (Tmix; i.e. α, β, γ, and δ-tocopherol) on body accumulation 
and immune cell functions of the lactating Holstein dairy cow.  Tissue, tissue 
mitochondria, blood and milk were collected from lactating dairy cows to measure the 
concentration of all four tocopherol isoforms via Tmix supplementation.  In addition, 
polymorphonuclear leukocyte (PMN) were isolated to investigate the effect of Tmix on 
its function and immune gene expression.  In the first experiment, Tmix increased γ-
 
 
tocopherol concentrations but did not increase the α-tocopherol concentration in three 
different types of tissues (i.e. liver, mammary gland and muscle) and liver mitochondria.  
Within those three different types of tissues, liver showed the highest ability to store 
tocopherol isoforms (i.e. α- and γ-tocopherol) compared to the other two tissues.  Also, 
amounts of α- and γ-tocopherol were detected in liver mitochondria, but limited amounts 
were detected in mammary gland mitochondria.  In the following experiment, Tmix 
increased γ-tocopherol concentration in milk and blood as determined via every 8 h and 
daily measurements.  Compared to γ-tocopherol, α-tocopherol showed the highest 
concentration of the tocopherol isoforms in milk and blood.  Limited quantities of β- and 
δ-tocopherol were detected in milk and blood via Tmix supplementation.  In the last 
experiment, Tmix increased PMN chemotaxis function and did not impair the whole 
blood respiratory burst response of dairy cows, which might be associated with non-α-
tocopherol existing in Tmix.  Even though Tmix increased the expression of pro-
inflammatory genes in PMN, those are needed during the initial immune activation.  
Overall, the results of the experiments demonstrated that short-term supplementation with 
Tmix could compensate γ-tocopherol without altering α-tocopherol in dairy cows.  The 
liver showed the highest capability of accumulating tocopherol isoforms compared to the 
mammary gland and muscle.  In addition, Tmix did not harm immune functions or have 
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CHAPTER 1: LITERATURE REVIEW 
Animals will encounter physiological stress from time to time.  For dairy cows, 
the high-risk period for disease and/or disorders is during the transition period, ± 3 weeks 
relative to parturition (Drackley, 1999).  At this time, dairy cows may suffer from other 
metabolic disorders (e.g. fatty liver and retained placenta) (Grummer, 1993) or infectious 
diseases (e.g. mastitis and metritis,) (Eckel and Ametaj, 2016).  These diseases are not 
only detrimental to the producer (i.e. economic loss), but also to animal health (Weiss, 
1998).  Within those two (metabolic disorders and infectious diseases), metabolic 
disorders are considered as a predisposing factor to infectious diseases (Bobe et al., 2004).  
Therefore, disrupted normal metabolic pathways need to be reversed to mitigate 
transition period issues (i.e. high diseases frequency) in dairy cows.  How can we 
minimize the negative consequences of disease at this time?  Before we can answer this 
question, we have to understand what could be the potential reasons causing the 
metabolic disorders and where we should focus in dairy cows during the stressful 
transition period.   
A recent review paper has shown us that liver is the particular place where 
disrupted metabolic processes happen, which can lead to clinical diseases in dairy cows 
(Bobe et al., 2004).  The disrupted metabolic process is partly explained by interrupted 
cell signal transduction pathways.  For example, insulin resistance could be partly 
explained by the disruption of  insulin-sensing pathways in dairy cows during the 
transition period (Sah et al., 2016).  Standard insulin receptor (i.e. receptor tyrosine 
kinase) activation requires the auto-phosphorylation of various tyrosine residues after 




al., 2017).  What could interrupt the above pathway resulting in insulin sensing fails?  
Recent study has shown that the Janus kinase 2 (i.e. non-receptor tyrosine kinase), which 
is activated by phosphorylation in the production of insulin-like growth factor 1 signal 
transduction pathways, could be attacked at phosphorylation activation sites, and lose 
activity by binding reactive nitrogen species (RNS; e.g. peroxynitrate): common stress 
mediator sensed by cells during infection and during periods associated with high stress 
(Elsasser et al., 2013).  In beef cattle, this event is called tyrosine nitration during 
inflammatory stress (Elsasser et al., 2012).  Therefore, we suggest that RNS could also 
attack the normal metabolic molecules (e.g. insulin receptor) during inflammatory stress, 
which is common in the transition period in dairy cows (Drackely, 1999).  Besides the 
insulin receptor signal transduction pathway, number of other key enzymes involved 
metabolic signal transduction pathways (e.g. mitogen-activated protein kinase, protein 
kinase B, etc.) are disrupted during metabolic diseases that might result from tyrosine 
nitration by RNS (Li et al., 2007).  Therefore, we propose that we can reestablish the 
normal cell signal transduction pathways or lessen the disrupted level by applying 
nutrient supplement strategies that target the reduction of reactive nitrogen molecules.  
Then the next question we would like to ask is ‘what nutrient compound could prevent 
the tyrosine nitration?’  A potential solution is to supplement γ-tocopherol, an isoform of 
vitamin E.  Recent study has shown that γ-tocopherol could bind with RNS before those 
species react with tyrosine in metabolic molecules involved with tyrosine kinase enzymes 
(Hoglen et al., 1997).  Alpha-tocopherol shows very limited ability to react with RNS due 




supplementing dietary γ-tocopherol to dairy cows may help animals pass through the 
stressful transition period.  
There is limited information for dairy cows regarding the bioaccumulation and 
concentration of γ- or other non-α-tocopherol (i.e. β- and δ-).  It is important to know 
how much of the different isoforms are distributed in tissues, blood or milk.  If a cow’s 
body does not absorb the γ- or other non-α-tocopherol past the liver and into blood or 
milk, then there is little point of focusing on the liver to mitigating the metabolic 
perturbations by using non-α-tocopherol.  Therefore, this project investigated the effects 
of Tmix (i.e. mixed tocopherol oil supplement; 9 % α-, 1 % β-, 24 % δ-, and 62 % γ-
tocopherol) on body accumulation and immune health in dairy cows.  There were three 
objectives of this study 1) to investigate the accumulation and distribution levels of all 
four tocopherol isoforms in tissue and mitochondria; 2) to investigate the change of all 
four tocopherol isoforms (α-, β-, γ- , and δ-tocopherol) in blood and milk over time; and 3) 
to investigate the effects of all four tocopherol isoforms on bovine polymorphonuclear 
leukocytes (PMN) function and immunometabolic-related gene expression via Tmix 
supplementation in dairy cows. 
Chemical Isoforms of Vitamin E  
Vitamin E is a group of compounds named tocochromanols (Traber and Atkinson, 
2007).  Tocochromanols consist of a chromanol ring system called the head region, and a 
hydrophobic prenyl side chain called the tail region.  Tocochromanols are divided into 
two groups, tocopherols and tocotrienols, which differ in the saturation of their 12-carbon 
lipid tails (saturated in tocopherols versus three double bonds in tocotrienols; Figure 1.1).  




differ in the number and position of methyl groups on the chromanol head group (Figure 
1.1).  Compared to tocotrienols, tocopherol has been used more commonly in the animal 
industry as a vitamin supplement.  There are two different types of tocopherols available 
commercially which are natural tocopherol (i.e. d-tocopherol) and synthetic tocopherol 
(i.e. dl-tocopherol).  For natural tocopherol, it only contains the RRR stereoisomer based 
on the position of the methyl group in C-2’ of the heterocyclic ring and C-4’ and C-8’ in 
the carbon tail.  For synthetic tocopherol, it includes all eight stereoisomers (i.e. RRR, 
RSR, RSS, RRS, SRR, SSR, SRS, and SSS) based on the position of methyl groups (i.e. 
either left “S” or right “R”) in C-2’ of the heterocyclic ring and C-4’ and C-8’ in the 
carbon tail and is called all-rac-tocopherol or dl-tocopherol (Traber, 2004).  Acetate and 
succinate derivatives of the natural tocopherol have vitamin activity, which are called 
esterified tocopherols, and the purpose of the derivatives was to extend shelf-life (Traber, 
2004).  Overall, vitamin E supplementation can be classified as either tocopherols or 
tocotrienols, and each one of them includes the α-, β-, γ-, or δ- isoform.  The resources 
and requirements of the different tocopherols will be discussed in later sections.     
The Roles of Vitamin E in Animals 
Vitamin E as an Antioxidant  
Vitamin E has been used in feed supplements for livestock for decades with 
dietary α-tocopherol acetate or succinate as the synthetic isoform most commonly 
employed in National Research Council (NRC, 2001).  Previous studies in dairy cows 
have shown that 7 µM of vitamin E (i.e. α-tocopherol) is the average cut-off value in 
serum, inadequate vitamin E (i.e. α-tocopherol) concentration in serum (<7 μM) may 




cows shortly after calving (Mudron et al., 1997; Weiss et al., 1997).  Recent studies also 
have shown that serum vitamin E (i.e. α-tocopherol) depletion (<7 µM) during the 
transition from later pregnancy to early lactation might contribute to the development of 
metabolic disorders such as left displaced abomasum and retained placenta (Qu et al., 
2013; Qu et al., 2014)  Vitamin E is considered a natural antioxidant via its role in 
controlling damage to host cell membranes during lipid peroxidation (Niki and Traber, 
2012).  Lipid peroxidation (Figure 1.2) refers to when free radicals (e.g. hydroxyl radical 
[•OH]) oxidize lipid membranes (e.g. poly-unsaturated fatty acids [PUFAs]) thereby 
producing lipid radicals (L•) and H2O.  In an aerobic environment, L
• can oxidize one free 
oxygen molecule, giving rise to a lipid peroxyl radical (LOO•).  Due to the high reactive 
properties, LOO• can continue to oxidize PUFAs to produce lipid hydroperoxide (LOOH) 
and an additional L•.  This lipid peroxidation chain reaction occurs continuously causing 
damage to the cell membrane and can lead to cell dysfunction (Serreli et al., 2017). 
Vitamin E is a molecular antioxidant that can inhibit the lipid peroxidation chain 
reaction by the following mechanism (Figure 1.3): vitamin E (i.e. α-tocopherol) donates 
the hydrogen from the hydroxyl group of the phenolic ring to LOO• producing a vitamin 
E free radical (E·) and an LOOH.  In addition to vitamin E, enzymes (i.e. glutathione 
peroxidase [GPX]) also play essential roles in scavenging reactive oxygen species (ROS; 
e.g. O2
• and H2O2) in cells (Figure 1.4; (Miller et al., 1993).  Superoxide dismutase (SOD) 
is the enzyme involved in catalyzing the dismutation of O2
• to H2O2.  Hydrogen peroxide 
could be reduced to H2O in the presence of GPX via the oxidation of glutathione (GSH) 
to glutathione disulfide (GSSG).  Finally, oxidized GSSG can be reduced to GSH in the 




Although highly unstable, ROS are required by phagocytic cells for the killing of 
invading microorganisms during the immune response via respiratory burst (Paape et al., 
2003) which will be discussed in more detail below.  However, ROS can also cause 
damage to host cells via the following potential mechanisms: 1) lipid peroxidation of the 
cell membrane (Figure 1.2); 2) oxidation of proteins, an important mechanism of O.2
- 
toxicity that is the direct oxidation and inactivation of iron-sulfur proteins, such as 
aconitases, and the associated release of iron (Fridovich, 1997), and 3) damage of 
deoxyribonucleic acid (DNA) molecules.  Reactive oxygen species could damage DNA 
molecules causing modification of the purine and pyrimidine base, the deoxyribose 
backbone, or single and double strand breaks (Gurler et al., 2016).  Therefore, the role of 
vitamin E as an antioxidant is essential for host cell viability and to help control host cell 
damage by ROS. 
Besides ROS, another common type of harmful free radical produced in animals 
is RNS (Rivera-Mancia et al., 2017).  One common form of RNS is the peroxynitrate. 
anion, which is a short-lived oxidant species that is produced by the reaction of nitric 
oxide (.NO) and O2
.- at diffusion-controlled rates at ~1×1010M-1s-1 (Figure 1.5).  When 
standard physiology systems are exposed to peroxynitrate or .NO, multiple biological 
effects can happen, with reversible effects on the viability and function of cells (Szabo et 
al., 2007).  Previous study has shown that productions of RNS are associated with 
diseases/disorders associated with e.g. inflammation, parturition, and immune 
suppression (Fubini and Hubbard, 2003).  Once RNS are produced, they could: 1) trigger 
cell death via mitochondria; 2) nitrate tyrosine residue in metabolic tyrosine kinase to 




well as cytosolic and nuclear receptors (Trachootham et al., 2008).  Among the above 
potential reversible effects via RNS, the nitration of protein tyrosine should be considered 
because many tyrosine residue kinases are involved in cell signal transduction pathways 
of normal physiological functions, like the growth hormone pathway and insulin receptor 
pathway (Schlessinger, 2000).   
Previous study using the peptide mapping method (Elsasser et al., 2012) have 
shown that one or two tyrosine residues in a protein become preferentially nitrated 
(Figure 1.6).  Once the nitration of tyrosine residues occurs, the site nitrated with RNS 
will not be available for natural cell signal transduction steps like phosphorylation needed 
in tyrosine kinase activation (Radi, 2013).  Besides the disruption of cell signal 
transduction via tyrosine nitration, the nitrated tyrosine could also initiate the 
polyubiquitination of nitrated proteins as a result of increased proteasome degradation or 
initiate the autoimmune process (Elsasser et al., 2012).  Therefore, compared to oxidative 
stress, the nitration of protein tyrosine uncovers the disruption of  nitric oxide (NO) 
signaling and metabolism towards the pro-oxidant process, referred to as nitroxidative 
stress in animals (Roberts et al., 2009).  Compared to α-tocopherol, γ-tocopherol shows 
more reactive ability with RNS due to its non-fully saturated phenol ring (Figure 1.1) 
(Hoglen et al., 1997).  Previous study has shown that γ-tocopherol could be nitrated by 
peroxynitrate at C-5 of the heterocyclic ring (Figure 1.7) in tocopherol to form nitrated γ-
tocopherol (NGT) (Patel et al., 2007).  Gamma-tocopherol could trap RNS before the 
nitration of tyrosine occurs to serve as an antioxidant.  Therefore, besides α-tocopherol, 
γ-tocopherol may serve as an antioxidant supplement to manage nitroxidative stress in 




Vitamin E as an Immune-Enhancer 
Besides a commonly used antioxidant, adequate vitamin E status plays a major 
role in immune function (Chew, 1995).  Cells involved in the immune system are rich in 
PUFAs and utilize oxygen radicals to combat pathogens (Sanchez Perez et al., 2006). 
Cows with depleted vitamin E status have depressed PMN function (Willshire and Payne, 
2011).  There are several potential mechanisms by which depleted vitamin E may 
indirectly impair immune function: a) increased lipid peroxidation decreases function and 
survival of immune cells, b) increased lipid peroxidation induces proinflammatory gene 
expression, c) increased lipid peroxidation modulates signal transduction; and d) low 
vitamin E modulates cell membrane structure and, thereby, alters cell signaling and cell-
to-cell communication (Chew, 1995).  The relationship between vitamin E and immune 
cells, mainly focused on PMN, will be discussed in later sections (pp. 17–21) 
Absorption and Transport of Vitamin E  
Absorption of Vitamin E  
There is limited information about the mechanism of vitamin E absorption in 
dairy cattle (Baldi, 2005; Bontempo et al., 2000).  In humans, the absorption efficiency 
for vitamin E is low (15-45 %) and decreases further in the absence of adequate 
pancreatic function, bile secretion, triglyceride (TAG) and cholesterol (Traber and Arai, 
1999).  In lactating cows, the bioavailability for oil-based all-rac α-tocopherol is 
estimated to be 47 % (Bontempo et al., 2000).  Figure 1.8 displays the steps of vitamin E 
absorption, starting with hydrolysis of the ester bond of lipids, including vitamin E esters, 
in the rumen and by pancreatic esterase in the duodenum (Frank, 2005; Toutain et al., 




ruminants by a greater taurine content, act as detergent to emulsify vitamin E from the 
insoluble particulate phase.  Next, vitamin E is incorporated into mixed micelles 
containing lipids and bile acids, which are then transported to the brush border membrane 
of the enterocytes for uptake (Goncalves et al., 2015).  
Tocopherol is absorbed in the proximal small intestine in all species (Traber, 
2014).  The mechanism of tocopherol absorption is not completely understood.  No 
intestinal tocopherol transfer proteins have been discovered.  Thus, it was assumed that 
tocopherol is absorbed by passive diffusion.  In in vitro intestinal model systems (Takada 
and Suzuki, 2010), the Niemann-Pick C1-Like 1 (NPC1L1) protein facilitates uptake of 
tocopherol and cholesterol (Narushima et al., 2008) by murine enterocytes.  Also, the 
scavenger receptor B-1 (SRB-1) promotes tocopherol and cholesterol efflux by murine 
enterocytes (Reboul et al., 2006). 
Vitamin E in Circulation  
After being absorbed by enterocytes, tocopherols are either bound to SRB-1 and 
packaged into high density lipoprotein ( HDL) complexes that are secreted into the blood 
(Anwar et al., 2007) or, in the presence of sufficient TAG and apolipoprotein B-100 
(ApoB), tocopherols are packaged into chylomicrons and secreted into the lymph system 
(Frank, 2005; Hidiroglou et al., 1994).  In circulation, vitamin E is transported with the 
lipoprotein fraction (Fairus et al., 2012); no particular tocopherol transport protein has 
been identified).  This explains why dietary vitamin E concentrations are adjusted for 
serum lipids, specifically cholesterol levels.  Lactating dairy cows have lower 
plasma/serum concentrations of α-tocopherol than humans (10-15 μM versus 20-40 μM).  




ruminants (Traber, 2013).  To my knowledge, the half-life of vitamin E in circulation in 
lactating dairy cows has not been determined.  The time until maximum vitamin E 
concentrations were obtained in blood is 57.5 h in dairy cows (Baldi, 2005).  In humans, 
the half-life of RRR-α-tocopherol in circulation is between 48 h (Traber, 2004) and 60 h 
(Bruno et al., 2006).  In contrast, SRR-α-tocopherol (Traber et al., 1994) and γ-tocopherol 
(Leonard et al., 2005) have a shorter half-life of 15 h.  In the endothelial capillaries, 
lipoprotein lipase hydrolyzes lipid esters.  Vitamin E is either a) taken up by target tissues 
through low density lipoprotein (LDL) receptors, b) taken up by tissue membranes, c) 
remains in chylomicron remnants, which are taken up by the liver, or d) is bound to HDL, 
which readily transfer vitamin E to other lipoproteins utilizing phospholipid transfer 
protein (PLTP) (Traber, 2013).   
Tissue Distribution of Vitamin E  
Knowledge about the movement of vitamin E within tissues is limited.  Vitamin E 
remains in the lipid soluble fraction of the tissue.  In the liver, to move α-tocopherol 
through the hydrophilic cytosol, α-tocopherol transfer protein (α-TTP), a 30 to 35 kDa, 
highly conserved, cytosolic, hydrophobic ligand binding protein is required, which moves 
α-tocopherol from liposomes to microsomes (Liu et al., 2014).  The α-TTP is primarily 
expressed in the liver but also at lower levels in brain, lung, kidney, and spleen (Traber, 
2013).  An absence of α-TTP in humans results in vitamin E deficiency and tissue 
damage (Niki and Traber, 2012).  Binding to α-TTP is highly specific to α-tocopherol, as 
α-TTP requires for binding three methyl groups in the chromanol ring, a phytyl tail, and 
the R-configuration at C-2 where the side chain is attached to the chromanol ring (Traber 




to α-TTP, which explains the much lower half-life and biological activity of other 
vitamin E forms.  Liver, specifically hepatic parenchymal cells, are the primary storage 
tissues for vitamin E, while the adrenal glands, spleen, kidney, and heart muscle also 
store vitamin E in rats (Table 1.1) (Uchida et al., 2012).  In general, body tissues have 
limited storage capacity for α-tocopherol.  The α-tocopherol exchange among tissues is 
relatively rapid; specifically among liver, erythrocytes, spleen, and serum/plasma 
(Hidiroglou et al., 1994).  Thus, serum/plasma concentrations provide an acceptable 
indicator of whole-body α-tocopherol status.  Heart, muscle, and spinal cord have a 
slower α-tocopherol exchange, while brain α-tocopherol transfer is slowest (Hidiroglou 
and Ivan, 1992).  Limited information of non-α-tocopherol concentration in bovine 
tissues is available.  Therefore, one objective of this project was to investigate the 
accumulation and distribution levels of all four tocopherol isoforms in bovine tissues.   
Transport of  Tocopherols from Liver and other Tissues  
Tocopherols stored in the liver are subsequently transferred to very-low-density 
lipoproteins (VLDL) to circulate in the blood for biological processes. The cytosolic 30- 
kDa α-TTP allows the incorporation of α-tocopherol into nascent VLDLs, which are 
released from the liver.  Alpha-tocopherol transfer protein belongs to the CRAL-TRIO 
family of lipid binding proteins (Panagabko et al., 2003) which specifically binds to α-
tocopherol.  Deletion of the α-TTP gene has been shown to contribute to vitamin E 
deficiency in mice (Terasawa et al., 2000; Yokota et al., 2001) indicating that α-TTP is 
essential for vitamin E transport and tissue distribution.  Once α-tocopherol is secreted 
from the liver, it is either exchanged to other lipoproteins or taken up by tissues via the 




liver is ATP-binding cassette transporter A1 (ABCA1), an ATP-binding cassette (ABC) 
transport protein, which facilitates α-tocopherol secretion mediated by α-TTP when Apo-
A1 is the acceptor protein (Traber, 2013).  Besides α-tocopherol, ABCA1 also facilitates 
transport of cholesterol and phospholipids out of cells into HDL (Reboul et al., 2006).  
Metabolism of Vitamin E 
Vitamin E does not accumulate to toxic levels in the liver.  As a consequence, 
efficient metabolism and excretion are crucial to maintaining vitamin E concentration 
(Traber and Atkinson, 2007).  So far, the only known site of vitamin E metabolism is the 
liver.  The first step of vitamin E metabolism is ω-hydroxylation of the lipid tail, 
followed by β-oxidation. Hepatic cytochrome P450 family 4 subunit 2 (CYP4F2) and 
cytochrome P450 family 3 (CYP3A) are involved in the tail shortening reaction, which 
occurs in the mitochondria (Traber, 2014).  High α-tocopherol concentrations promote 
the tail-shortening reaction of α-tocopherol as well as γ-tocopherol.  The primary end 
products of the tail shortening reaction are α-CEHC (2,5,7,8-tetramethyl-2-(2
’
-
carboxyethyl)-6-hydroxychroman) for α-tocopherol and γ-CEHC (2,7,8-trimethyl-2-(2
’
-
carboxyethyl)-6-hydroxychroman) for γ-tocopherol,  which are both found in plasma and 
urine (Birringer et al., 2002; Lodge et al., 2001).  
Excretion of Vitamin E  
To increase water solubility, CEHCs are sulfated or, to a smaller extent, 
glucuronidated (Pope et al., 2002) before being excreted into urine or bile (Brigelius-
Flohe and Traber, 1999; Traber and Arai, 1999).  In the biliary excretion, multidrug 
resistance gene product 1 and 2 are involved (Traber, 2014).  In addition, because of the 




in small amounts in feces (Frank, 2005; Hidiroglou et al., 1994).  Compared to α-
tocopherol, limited information is available on body accumulation of γ-tocopherol and its 
interactions with RNS in dairy cows. 
Dietary Sources of Vitamin E in Dairy Cows 
The main dietary vitamin E supplements are α- and γ-tocopherol (Table 1.2).  
Alpha-tocopherol is the most biologically active tocopherol isoform in the body (Traber 
and Atkinson, 2007).  Main dietary sources of α-tocopherol are oils and forages.  In the 
absence of fresh forages, cows become rapidly vitamin E depleted (McDowell et al., 
1996).  The vitamin E content in cow feed (i.e. forage) is highly variable (Table 1.3) and 
differs depending on plant species, stage of maturity, environmental conditions, time of 
cutting, time cutting to dehydration, processing and storing conditions (Jukola et al., 
1996; McDowell et al., 1996).  Rapid losses of vitamin E in the diet might occur under 
oxidative conditions, such high temperature, moisture, oxygen, and pelleting (McDowell 
et al., 1996).  Due to the high chances of losing vitamin E in stored forages (Table 1.3), 
the vitamin E requirement of dairy cows cannot be reached by only providing forages for 
non-pasture-fed dairy cattle.  Therefore, vitamin E supplements are needed to maintain 
animal health.  
Vitamin E Requirements in Dairy Cows 
Current NRC recommendations for α-tocopherol in dairy cows are 2.6 IU/kg of 
body weight (BW), which includes vitamin E from feed-stuffs and supplements (NRC, 
2001).  One marker to assess vitamin E adequacy is to measure serum/plasma 
concentrations of α-tocopherol.  Serum vitamin E concentrations below 3 μg/mL are 




white muscle disease, can be observed at concentrations below 1.5 μg /mL (McDowell et 
al., 1996).  Concentrations of 1.5 or 2-3 μg/mL (equivalent to 7 μM in serum/plasma) are 
considered marginal, whereas higher α-tocopherol of at least 3 or 4 μg/mL is required for 
adequacy (McDowell et al., 1996; NRC, 2001).  To reach adequate blood values, current 
NRC recommendations for supplemental α-tocopherol in dairy cows are 1.6 IU/kg BW 
(approximately 80 IU/kg of dry matter intake [DMI]) during the dry period and 0.8 IU/kg 
BW (approximately 20 IU/kg DMI) during lactation (NRC, 2001).  The following 
recommendations may be insufficient during times of low feed intake or increased 
vitamin E excretion, such as in the first weeks postpartum.  In addition, greater amounts 
of vitamin E supplements are needed when vitamin E-deficient forages, concentrates, or 
total mixed rations (TMR) are fed, when forages of poor quality are fed, when harvesting, 
drying or storage conditions have decreased vitamin E content, when other feed 
components require higher vitamin E doses (e.g., PUFA, high nitrates in water), or when 
cows have greater requirements for production, feed efficiency, or to combat stress or 
disease (McDowell et al., 1996).  In contrast, if fresh forages are fed or cows are on 
pasture, vitamin E supplementation needs are reduced.  Feeding extra vitamin E may also 
increase the proportion of PUFAs in the milk of pasture-fed cattle and reduce oxidized 
flavors (Johansson et al., 2014).  Thus, some experts recommend injectable vitamin E for 
cows two weeks before calving (McDowell et al., 1996; Weiss et al., 1998; Baldi, 2005; 
Politis, 2012).  Compared to α-tocopherol, the required amounts for supplementing other 
tocopherol isoforms (e.g. γ-tocopherol, which was needed to protect against RNS) are 
unknown. 




The most natural stress period for dairy cows is the transition period, defined as ± 
3 weeks relative to parturition (Drackley, 1999).  During this time, dramatic 
physiological changes occur which might lead to altered immune and inflammatory 
responses in dairy cows (Sordillo and Raphael, 2013).  The sudden physiological changes 
and altered immune functions contribute to the increased incidence of production 
diseases (e.g. metabolic disorders or infectious diseases) (Esposito et al., 2014).  The 
severe infectious disease of mastitis will be discussed in a later section (pp.18).  Another 
factor may be free radical stress (i.e. oxidative [via ROS] or nitroxidative stress [via 
RNS]) (Gaal et al., 2006).  The free radical stress occurs when there is an imbalance 
between the production of free radical molecules and host antioxidant (e.g. vitamin E 
depletion) capabilities (Bobe et al., 2017).  The potential over production of free radical 
molecules might be associated with sudden physiological changes (i.e. preparation for the 
ensuing lactation) in transition cows (Sundrum, 2015) or due to the proinflammatory 
immune response (Mordak and Anthony, 2015).  Reduced host antioxidant capabilities 
may occur with reduced feed intake in dairy cows during the transition period because the 
dietary source is the primary way of giving vitamin supplements to dairy cows 
(Schirmann et al., 2016).  For these two free radical stresses, oxidative stress has drawn 
more attention than nitroxidative stress, and α-tocopherol has been used as the essential 
antioxidant supplement in dairy cows compared to γ-tocopherol.  However, nitroxidative 
stress is detrimental to dairy cattle health as well, especially related to disrupted 
metabolic pathways (Li et al., 2007).  Previous studies have shown that nitrated tyrosine 
kinases (e.g. JAK-2) happen via the production of peroxynitrite (a RNS) (Elsasser et al., 




phosphorylation reactions involved in regular cell signal transduction pathways (e.g. 
insulin receptor, or growth hormone receptor etc.) (Kong et al., 1996).  Those 
perturbations of cell signal transduction pathways contribute to severe metabolic issues 
(e.g. insulin resistance) in dairy cows during the transition period (Boneh, 2015).  
Therefore, besides α-tocopherol, the more reactive tocopherol isoforms, γ-tocopherol, to 
protect against RNS is needed as an extra vitamin E supplement in dairy cows.    
Vitamin E and Mitochondrial Health 
Mitochondria are one of the essential cell organelles within a cell (Chan, 2006).  
The main function of mitochondria is the production of adenosine triphosphate (ATP) for 
energy utilization via oxidative phosphorylation and O2 consumption to regulate cell 
metabolism (Orrenius et al., 2007).  Oxidative phosphorylation refers to the process that 
ATP is formed as a result of the transfer of electrons from nicotinamide adenine 
dinucleotide (reduced form) NADH or flavin adenine dinucleotide (reduced form) 
FADH2 (NADH or FADH2 from citric acid cycle) to reduce O2 to H2O through a series of 
electron carriers (Orrenius et al., 2007;  Figure 1.9).  
When electrons (derived from NADH or FADH2) are transported through the 
electron transport chain via NADH-Q oxidoreductase (complex I), Q-cytochrome c 
oxidoreductase (complex III), and cytochrome c oxidase (complex IV), protons (H+) are 
pumped from the matrix of the mitochondria to the cytosolic side of the inner 
mitochondrial membrane.  The resulting unequal distribution of protons generates a 
proton gradient; ATP is synthesized when protons flow back to the mitochondrial matrix 
through ATP synthase.  However, during electron transport in the inner membrane, O2
• 




be to the precursor of peroxynitrite in the presence of NO (Murphy, 2009).  Peroxynitrite 
can reduce to bicarbonate (HCO3
-), which leads to the formation of carbonate (CO3
●-) 
and nitrogen dioxide radicals (.NO2).  Nitrogen dioxide radicals can play the same roles 
as LOO●, leading to lipid peroxidation (Szabo et al., 2007).  Both ROS and RNS can 
contribute to free radical stress and result in cell damage via lipid peroxidation (Szabo et 
al., 2007; Valko et al., 2007).   
A previous study has shown that mitochondria are essential cell organelles related 
to cell death during oxidative stress (Elsasser et al., 2012).  Increased production of ROS 
or RNS will contribute to mitochondrial dysfunction, leading to cellular apoptosis 
(Orrenius et al., 2007).  One proposed mechanism of action is shown in Figure 1.10.  In 
the cytosol, ROS or RNS mediates cardiolipin peroxidation (lipid peroxidation) 
exclusively in the inner mitochondrial membrane.  This then initiates the release of 
cytochrome c (Cyt c) into the cytosol where Cyt c activates capase-9 leading to cellular 
apoptosis (Fariss et al., 2005). 
Tocopherols can control cardiolipin peroxidation via scavenging of ROS as 
shown in Figure 1.2.  Also, vitamin E isoforms (e.g. γ-tocopherol) can scavenge reactive 
nitrogen species (i.e. peroxynitrite, NO2) through γ-tocopherol nitration, which, like ROS, 
can damage proteins, lipids, and DNA (Traber and Nikki, 2012).  However, the 
absorption of tocopherol isoforms (α-, β-, γ- and δ-tocopherol) in mitochondria (mainly in 
lipid membranes) in tissues from dairy cows is still unclear.  This project will determine 
the bioaccumulation of a dietary tocopherol mix containing α-, β-, γ- and δ-tocopherol in 
mitochondria within primary peripheral tissue types (i.e. liver and mammary gland) of 




Vitamin E Might Help to Improve Polymorphonuclear leukocytes (PMN) Functions 
during Inflammation 
Mastitis 
Mastitis is defined as an inflammation of the mammary gland. Bovine mastitis is a 
disease of high economic importance.  Financial losses associated with mastitis at the 
farm-level are mainly due to treatment costs, loss of milk yield, and lower milk quality 
(Blum et al., 2014).  In dairy cows, mastitis is usually associated with the invasion of 
microorganisms, primarily bacteria.  Mastitis-causing pathogens can be mainly classified 
into two categories: environmental and contagious (Zhao and Lacasse, 2008).  
Contagious mastitis pathogens within the mammary gland of infected cows are the 
primary source of infectious pathogens in a dairy herd because the contagious organism 
is well adapted to survival and growth in the mammary gland lasting weeks, month or 
years (Fox and Gay, 1993).  Transmission of contagious pathogens to uninfected quarters 
and cows usually occurs during the milking process.  Milk from infected quarters can 
contaminate milking machines, hands of milkers, and towels, which act as reservoirs of 
infection.  The major contagious pathogens are Staphylococcus aureus and Streptococcus 
agalactiae.  These bacteria can be effectively controlled by procedures who prevent 
spread of bacteria at milking time through good udder hygiene, proper milking 
procedures, and post-milking teat disinfection.  Use of dry cow antibiotic therapy can 
help eliminate existing infections and prevent new infections during the early and late dry 
period (Sol et al., 1994). 
Mycoplasmas are another important contagious mastitis pathogen (Fox and Gay, 




can be spread during milking.  There is no effective treatment for mycoplasma mastitis, 
but the disease can be controlled by identifying infected animals, followed by segregating 
and/or culling the infected animals (Fox and Gay, 1993).  
In addition to contagious pathogens, environmental pathogens also cause mastitis.  
The primary source of environmental mastitis pathogens is the habitat of the cow (soil, 
plant material, manure, bedding, and contaminated water) (Anderson et al., 1982).  The 
most frequently isolated environmental pathogens are several species of streptococci 
(gram-positive bacteria) and coliforms (gram-negative bacteria).   
The endotoxin of gram-negative bacteria (e.g. Escherichia coli; E. coli) inducing 
the inflammatory response is lipopolysaccharide (LPS) on the cell wall, which is the 
pathogen-associated molecular pattern (PAMP).  The PAMP will be recognized by 
pattern recognition receptors (PPR; e.g. toll-like receptors [TLR] and chemokine 
receptors) which are expressed on the surface of immune cells (e.g. macrophage, PMN, 
B-lymphocytes) or other cell types (e.g. epithelial cells).  The binding of the PAMP to the 
PPR can activate the inflammatory response through MyD88 (myeloid differentiation 
primary response protein 88)-dependent pathway that leads to the production of 
inflammatory cytokines (Figure 1.11).  When PPR are activated by PAMP, TLR hetero- 
(e.g. TLR-2 and TLR-6) or homo-dimerize (e.g. TLR-4), inducing the recruitment of 
adaptor proteins via the cytoplasmic TLR domain.  Adaptor proteins include the TLR-
domain-containing proteins: MyD88 TIRAP (TLR-associated protein), Mal (MyD-88 
adaptor–like protein), TRIF (TLR-domain-containing adaptor protein inducing IFN-β 
(Interferon beta-1), and TRAM (TRIF-related adaptor molecule).  After recruitment of 




associated kinase 4 (IRAK-4) are activated. IRAK-4 subsequently activates IRAK-1 by 
phosphorylation.  Both IRAK1 and IRAK-4 leave the MyD88-TLR complex and 
associate temporarily with tumor necrosis factor (TNF) receptor-associated factor 6 
(TRAF-6) leading to its ubiquitination (Sun, 2004).  Following ubiquitination, TRAF-6 
forms a complex with TAB-2/TAB-3/TAK-1 inducing TAK-1 (transforming growth 
factor-β-activated protein kinase 1) activation (Kanayama, 2004). TAK1 then couples to 
the IκB kinase (IKK) complex, which includes the scaffold protein leading to the 
phosphorylation of IκB and the subsequent nuclear localization of NF-κB (nuclear factor 
kappa-light-chain-enhancer of activated B cells).  Activation of NF-κB can trigger the 
production of pro-inflammatory cytokines such as TNF-α, IL-1, and IL-12 (Kanayama, 
2004). 
Bovine Blood PMN and Vitamin E during Inflammatory Response 
Sensing the pathogens by initiating inflammation is crucial to the recruitment of 
PMN in mammary tissues of dairy cows (Rainard and Riollet, 2006).  Bovine mammary 
epithelial cells and milk macrophages could first detect pathogens and initiate an 
inflammatory response following the mechanisms discussed above.  During the 
inflammatory response, circulating neutrophil infiltrate from the blood into the mammary 
gland through a process called chemotaxis (Figure 1.12) and serve as the primary defense 
mechanism of the innate immune system (i.e. non-specific immunity) against invading 
microorganisms.  The PMN play an important role during the innate immune response.  
During an infection, PMN migrate from blood to the tissue in response to 
chemoattractants secreted from either resident macrophages or the epithelial cells 




as IL-1, IL-2, and IL-8 (Furie, 2014).  Cytokines activate the endothelial cells to express 
E-selectin and P-selectin which bind tightly to circulating PMN (Radi et al., 2001).  This 
binding enhances expression and adhesiveness of another PMN adhesion molecule, Mac-
1 (also known as CD11b/ CD18), which is a member of the β2-integrin family of 
leukocyte adhesion molecules. At the same time that Mac-1 expression increases, L-
selectin is proteolytically shed from the PMN surface (Kishimoto et al., 1989).  The Mac-
1 molecule allows PMN to bind tightly to activate endothelium via another endothelial 
adhesion molecule, ICAM-1 (intercellular adhesion molecule 1).  This binding allows 
PMN to migrate from the endothelial surface into the infected tissue via a process called 
diapedesis along a concentration gradient of chemoattractants, the most important being 
complement components C5a and IL-8 (Ranard and Riollet, 2006).  Bovine PMN 
expresses chemokine receptors (i.e. CXCR-1 and CXCR-2), which can recognize CXC 
chemokines (e.g. C5a).  These chemokine receptors have been used as potential genetic 
markers for PMN function (Yongerman et al., 2004).  Once within the infected tissue, 
PMN phagocytose and kill invading microorganisms via respiratory burst.  Phagocytosis 
is the process of ingesting of microorganisms by phagocytic cells (e.g. macrophages, 
PMN) (Paape et al., 1979) (Figure 1.13).  The first step of phagocytosis requires the 
adherence or opsonization of phagocytic cells to the cell wall of bacterial (e.g. endotoxin 
LPS from gram-negative bacteria).  Phagocytic cells receptors (e.g. TLR) are specific for 
certain opsonins, such as the component of complement, boost adherence and 
phagocytosis (Goldsby, 2000).  After the microorganism is surrounded and enclosed by 
pseudopodia from the phagocytic cells, it then enters the cytosol with a membrane 




phagolysosome.  During this fusion, a burst of oxidative metabolism called respiratory 
burst occurs in activated phagocytes.  During this respiratory burst, PMN generate ROS 
(i.e. O2, H2O2) to damage the cell membrane of engulfed microorganisms. Nicotinamide-
adenine-dinucleotide-phosphate linked oxidase can catalyze the reduction of O2 to O2
..  
Superoxide anion is extremely toxic to ingested bacteria, can generate H2O2 via SOD.  In 
addition to SOD, myeloperoxidase activity produces HClO (hypochlorous acid) from 
H2O2, which is also toxic to ingested microorganisms.  However, these ROS can also 
damage the host cell membranes through lipid peroxidation (as demonstrated in Figure 
1.1), oxidation of proteins, or damage of DNA molecules (Halliwell and Aruoma, 1991).  
Therefore, understanding how to improve PMN function and prevent host cell damage 
from respiratory burst activity is an essential step to the development of new strategies to 
control mastitis and improve the health of dairy cows. 
Previous studies have shown that α-tocopherol supplements besides antioxidant 
enzymes (e.g. SOD and GPX) can improve bovine PMN phagocytosis and chemotaxis 
(Ibeagha et al., 2009; Politis, et al., 2012) as an immune enhancer in vitro.  At the same 
time, previous study also has shown that tocopherols (e.g. α-, γ-, δ-tocopherol) and 
tocopherol metabolites (water-soluble 2, 2’-carboxyethyl hydroxychroman metabolites) 
can control the PMN oxidative burst to produce ROS or RNS during PMN stimulation 
from human blood in vitro (Varga et al., 2008).  However, the effects of β-, γ- and δ-
tocopherol on PMN function are still unknown in bovines.  Therefore, this project will 
determine the effects of feeding a tocopherol mix (four tocopherol isoforms- α-, β-, γ- 
and δ-tocopherol) on bovine PMN function and the expression of genes involved in 




Overall, vitamin E supplements are necessary to maintain dairy cow health during 
the transition period when vitamin E deficiency occurs (Johansson et al., 2014).  Among 
those four vitamin E isoforms, non-α-tocopherols (e.g. γ-tocopherol) are needed as 
importantly as α-tocopherol to protect against RNS (Shi et al., 2013).  However, basic 
information on bioaccumulation and distribution of mixed isoforms (i.e. highly enriched 
with γ-tocopherol) of vitamin E and their effects on animal health (i.e. specifically 
immune cell function) in dairy cows are needed.  For instance, will the non-α-tocopherol 
isoforms be accumulated at the high level equal to α-tocopherol?  Will the mixed 
isoforms tocopherol alter immune cell functions?  We must understand those two basic 
and important questions before applying mixed isoforms of vitamin E supplements in 
dairy cow management.  
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Table 1.1: Tissue α-tocopherol concentration (μg/g fresh tissue) in Holstein steers after a single gastric 











































Table 1.2: Vitamin E content of oils, cereal grains and seeds (per kg edible portion) (adapted from Packer 
and Fuchs, 1993). 
Product Tocopherol (mg) Tocotrienol (mg) 
 α β γ δ α β 
Oils       
Canola 210 1 42 0.4 0.4 - 
Corn 112 50 602 18 - - 
Cottonseed 389 - 387 - - - 
Olive 119 - 7 - - - 
Palm 256 - 316 70 146 32 
Peanut 130 - 214 21 - - 
Soybean 75 15 797 266 2 1 
Grains       
Barley 2 0.4 0.3 0.1 11 3 
Corn 6 - 45 - 3 - 
Oats 5 1 - - 11 2 
Seeds       
Sesame - - 227 - - - 
















Table 1.3: Vitamin E content of feed in mg/kg (adapted from Cort et al., 1983; Muller et al., 2007; 
Mogensen et al., 2012). 
Product Tocopherol (mg/lbs) Tocotrienol (mg/lbs) 
 α β γ δ α β 
Alfalfa, fresh 255.74 - 11.02 - - - 
Alfalfa,hay 68.34 - 4.41 - - - 
Fresh grass 116.84 - - 8.81 - - 
Grass silage 74.96 - - 11.68 - - 
Grass hay 52.91 - - 3.53 - - 
Fresh grass silage 69.67 - - - - - 
Stored grass silage 65.48 - - - - - 
Fresh corn silage 62.83 - - - - - 
Stored corn silage 28.00 - - - - - 
Fresh grain silage 112.44 - - - - - 








Figure 1.1: Chemical structures of tocopherols and tocotrienols (Lampi, 2011) 
 
Figure 1.2: Lipid peroxidation chain reaction (adapted from Valko et al., 2004) 
 







Figure 1.4: The roles of antioxidant enzymes during respiratory burst. GPX = glutathione peroxidase; GSH 
= glutathione; GSSG = glutathione disulfide (adapted from Jia et al., 2012). 
 
Figure 1.5: Biochemistry of peroxynitrite: Peroxynitrite anion (ONOO-) is in equilibrium with 
peroxynitrous acid (ONNOOH;pKa=6.8) and either one can undergo direct reactions with biolecules as 
indicated (a and b), ONNO- react with CO2 (c), which leads to the formation of carbonate (CO3.-) and 
nitrogen dioxide (.NO2) (d), Alternatively, ONNOH could diffuse into lipid bilayer (e), which yields .NO2 











Figure 1.6: Molecular model of the reaction between ONNO- and tyrosine residual, which reacts 
spontaneously with favorable targets such as the C-3 of phenolic ring of tyrosine. Then significantly 

















Figure 1.9: The donation of electrons for the generation of ATP during oxidative phosphorylation. 
Complex I: NADH-Q oxidoreductase, Complex III: Q-cytochrome c oxidoreductase, Complex IV: 
cytochrome c oxidase. NADH= Nicotinamide adenine dinucleotide (reduced form): FADH2=Flavin 










Figure 1.11: Toll-like receptor signaling pathway. PAMPs= Pathogen associated molecular pattern, 
TIRAP=Toll like receptor associated protein, MyD-88= Myeloid differentiation primary response 88, 
IRAK-1= Inerleukin-1 receptor associated kinase 1, IRAK4= Interleukin-4 associated kinase 4, TRAF-6= 
TNF receptor associated factor 6, TAK-1/TAB/2/3= transforming growth factor-β-activated protein kinase 






Figure 1.12: Chemotaxis in bovine PMN. PMN= Polymorphonuclear leukocytes. Mac-1= adhesion 
molecules, ICAM-1= Intercellular adhesion molecule 1, C5a= Complement component 5a, IL-1= 








CHAPTER 2:THE DISTRIBUTION OF TOCOPHEROL ISOFORMS IN BOVINE 
TISSUES AND TISSUE MITOCHONDRIA VIA SHORT-TERM MIXED 
TOCOPHEROL OIL SUPPLEMMENTATION 
ABSTRACT 
Vitamin E supplements are needed to protect tissue and mitochondrial integrity.  
However, limited information of non-α-tocopherol distribution is available in dairy cows.  
The objective of this study was to determine the pattern of change in the concentrations 
of 4 isoforms of tocopherol (α-, β-, γ-, and δ-tocopherol) in tissue and mitochondrial 
fractions from bovine liver and mammary gland after short-term feeding of a vegetable-
derived oil particularly enriched with γ- and δ-tocopherols (9 % α-, 1 % β-, 24 % δ-, and 
62 % γ-tocopherol).  Nine healthy, multiparous Holstein cows (> 90 days in milk) were 
assigned to dietary control (Control; n = 4) or tocopherol-fed treatment groups (n = 5; 
mixed tocopherol oil supplement [Tmix]; ~260 g Tmix/cow∙d-1, top-dressed) and fed for 
9 consecutive days.  On d 10 of feeding, tissues were harvested at slaughter and 
mitochondria were isolated. Tocopherol isoform concentrations were determined by 
HPLC (high-performance liquid chromatography) and data were analyzed as a complete 
randomized design.  Non-detectable values were obtained for the concentrations of β- and 
δ-isoforms in tissues and mitochondria.  Concentrations of γ-tocopherol increased (0.008 
vs.0.03 µg/mg) in liver mitochondria from Tmix cows compared to Control cows.  In 
tissues and mitochondria, the α-isoform concentrations were higher than the γ-isoform.  
The accumulated portions of the α-isoform to the γ-isoform were similar for 
mitochondria and tissues regardless of tissue source.  Regardless of tocopherol isoform or 




tocopherol concentrations compared to the mammary gland (8.2 vs.2.7 µg/g, 
respectively).  In conclusion, the liver had higher tocopherol (α- and γ-isoforms) 
concentrations than the mammary gland suggesting that the liver may be preferred over 
the mammary gland for tocopherol accumulation.  The α-isoform accumulated at higher 
concentrations than the γ-isoform in liver perhaps due to a higher affinity of tocopherol 
transport and binding proteins for α-tocopherol than the γ-isoform. 
INTRODUCTION 
Vitamin E is one of the most critical and abundant lipid-soluble antioxidant agents 
in circulating blood and cells of dairy cattle (Rigotti, 2007).  Vitamin E divided into two 
main groups, tocopherols or tocotrienols, based on differences in the degree of saturation 
of carbon tails (Blatt et al., 2001).  In the agricultural animal industry, tocopherols are the 
more predominate vitamin E supplement compared to tocotrienols (Brigelius-Flohe and 
Traber, 1999).  Within tocopherols, there are four different isoforms (α-, β-, δ-, or γ-) 
based on the differences in the number and position of methyl groups on the chromanol 
head group (Jarvinen and Erkkila, 2016).   
The distribution of tocopherols (α-, β-, γ- and δ) in major metabolic tissues (e.g. 
liver and mammary gland) in dairy cattle remains unclear.  After being absorbed by 
enterocytes, tocopherols have two fates where they are either  bound to scavenger 
receptor class B member-1 and packaged into high-density lipoprotein complexes that are 
secreted into the blood circulation (Anwar et al., 2007), or are packaged into 
chylomicrons and secreted into the lymph system, in the presence of sufficient TAG and 




the liver via the portal vein due to the expression of the (SEC14L2) and the α-TTP (Meier 
et al., 2003).  
Among the tocopherol isoforms, α-isoform has been studied the most and displays 
preferential affinity to α-TTP and SEC14L2 compared to other isoforms (Dutta-Roy et al., 
1994; Kaempf-Rotzoll et al., 2003).  This affinity may partly explain the high α-
tocopherol accumulation level in the liver and the high bioavailability in animals (Traber, 
2007).  In the liver, tocopherols will be reassembled with lipoproteins, cholesterol, and 
TAG then secreted into the blood for uptake into to other peripheral tissues (Mustacich et 
al., 2007).  In dairy cattle, the liver plays a vital role with regard to tocopherol 
transportation and storage.  However, the information regarding the distribution levels of 
other tocopherol isoforms (i.e. β-, δ-, and γ-) in peripheral tissues (i.e. mammary gland 
and muscle) remains to be elucidated in dairy cattle.   
In the mitochondria, tocopherol accumulation is needed to protect mitochondrial 
health (Lauridsen and Jensen, 2012).  Mitochondria are vulnerable to oxidative stress and 
nitrative stress during diseases/disorders or during periods when the metabolic stress is 
high (Kagan et al., 2007; Yapici et al., 2015).  Previous studies have shown that α-
tocopherol can be accumulated in mitochondria at high levels after feeding, which is 
based on the assumption that α-tocopherol is mainly co-localized with docosahexaenoic 
(DHA) in the non-lipid raft membrane fraction of cells (Atkinson et al., 2008; Li and 
May, 2003).  Previous study has shown that mitochondria contain 35-40 % of the α-
tocopherol present in hepatocytes in rodents, which indicates that the mitochondria is the 
main site to accumulate tocopherol in cells (Li and May, 2003).  In addition, Mustacich et 




mitochondria via the β-oxidation process in rodents to avoid potential toxicity.  Similar to 
tissues described above, the information on the accumulation level of non-α-tocopherols 
(i.e. β-, δ-, and γ-isoforms) in mitochondria is unknown.  Therefore, the objective of this 
study was to investigate the accumulation and distribution level of all four tocopherol 
isoforms (i.e. α-, β-, δ-, and γ-) in tissues (i.e. liver, mammary gland and muscle) and 
mitochondria (i.e. liver and mammary gland) via short-term mixed tocopherol oil 
supplementation (Tmix).  The hypotheses are that Tmix will increase non-α-tocopherol 
isoforms (i.e. β-, γ-, and δ-) in tissue and tissue mitochondrial fraction after 9 d feeding. 
MATERIALS AND METHODS 
All procedures involving the use of live animals were approved in accordance 
with the regulations and guidelines set forth by the U.S. Department of Agriculture, 
Beltsville (# 15-009), Animal Care and Use Committee and were approved by the 
Institutional Animal Care and Use Committee at the University of Maryland, College 
Park (# 626721-1). 
Animals and Treatments 
 Nine multiparous Holstein cows in mid-lactation (DIM = 179 ± 17) were used for 
this study.  Dairy cows were fed either a mixed tocopherol oil supplement (Tmix) or no 
supplement (Control) for 9 d consecutively.  Cows were housed and fed in tie-stalls each 
with its own feed bunk, had free access to water and were milked twice daily at 0600 h 
and 1800 h.  Cows were fed on average 22.7 ± 2 kg DM (dry matter) divided into two 
equal portions with the first allotment put into the feed bunk at 0700 and the second at 
1400 h.  The diet fed was a TMR formulated to meet NRC requirements (2001) 




17.03 % CP (crude protein)/kg DM (Table 2.1) for lactating dairy cows averaging 90 
DIM and producing 40 kg of milk/d with a mean BW and body condition score of 598 kg 
and 3.0 on a 5-point scale (Ferguson et al., 1994), respectively.  The supplementation of 
the daily TMR with the four isoforms of tocopherols was accomplished by adding a 
concentrated mixed tocopherol oil (Cargill Innovation Center, Velddriel, Netherlands; 
isoform composition: 9 % α-, 1 % β-, 24 % δ-, and 62 % γ-tocopherol) to a commercial 
molasses-sweetened calf grower diet (Farmers Cooperative Association Inc., Frederick, 
MD) as the carrier.  To prepare this, 300 g of the concentrated mixed tocopherol oil was 
blended into 22.68 kg of calf grower diet to generate the Tmix.  Based on a previous 
study (Elsasser et al, 2013) the Tmix was added at ~620 g/cow∙d-1 into a small pocket 
formed in the top of the TMR at the morning feed.  From the Tmix supplements, each 
individual cow received 740 mg α-, 80 mg β-, 5080 mg γ- and 1970 mg δ-tocopherol.  
Besides the Tmix supplements, each cow received 1442 ± 86 mg α-, 0 (i.e. non-
detectable) mg β-, 355 ± 5 mg γ- and 89 ± 21mg δ-tocopherol from the basal diet. Cows 
in the tocopherol-supplemented group (n = 5) were provided the Tmix for 9 d 
consecutively (i.e. Tmix group).  Cows in the Control group (n = 4) were fed the standard 
TMR for lactating dairy cows (Table 2.1; Control group).  For the Control group, cows 
received tocopherol isoforms only as contained in the basal TMR.  After 9 d of feeding, 
all cows were sacrificed and liver, mammary tissue, and triceps brachii muscle tissue 
were collected and stored at -80 ºC until further analysis. 
Tissue Tocopherol Isoform Analysis 
Approximately 20 g of tissue was shipped to the CTI Nutrition Laboratory (Craft 
Technologies, Inc., Wilson, NC) for tocopherol isoform concentration analysis via high-




et al. (2007).  Briefly, tissue samples (i.e. liver, and triceps brachii muscle) were 
homogenized with a polytron, and mammary tissues were homogenized with dry ice.  
After homogenization, tissue samples: liver (~1.4 g), muscle (~2.8 g) and mammary 
tissue (~2.5 g) were saponified by heating with 0.5-0.6 mL of 10 % pyrogallol in ethanol, 
and 2-2.5 mL 40 % KOH in methanol at 70 °C for 60 min, then neutralized with HCl.  
After saponification, samples were extracted 3 times with 5 mL of 80:20 (hexane:THF 
[tetrahydrofuran]) then washed 3 more times with water and then dried.  Twenty μL of 
sample were injected into the HPLC system.  For HPLC, the separation was performed 
using the ThermoSeparations Products HPLC system (Thermo-Fisher Scientific Inc., 
Pittsburgh, PA) with a Chromegabond Diol column (ES Industries, 3 µm, 150 x 4 mm), 
equipped with an FL3000 fluorescence detector and a UV2000 programmable UV/visible 
detector. The mobile phase was 4 % dioxane in hexane pumped at 1.0 mL/min and a run 
time of 20 min. The UV detector was set at 269 nm and the fluorescence detector was set 
at 290 nm excitations and 340 nm emissions. 
Tissue Mitochondrial Isolation 
Liver and mammary tissue mitochondria were isolated via the commercially 
available mitochondrial isolation kit from Abcam (Abcam Biotechnology company, 
Cambridge, UK).  The protocol was adjusted to maximize the number of mitochondria 
isolated.  Briefly, ~2 g of tissue were washed 2 times with washing buffer.  Tissues were 
then transferred to the Potter-Elvehjem tissue grinder with addition of 8 mL of isolation 
buffer for tissue homogenization.  The purpose of using Potter-Elvehjem grinder was to 
protect the integrity of the mitochondria.  After grinding, homogenized tissues were 




After centrifugation, the supernatant was collected and transferred to a high-speed 
centrifuge tube (Beckman Coulter Life Sciences, Indianapolis, IN) for 12,000 × g 
centrifugation for 15 min at 4 °C.  After the first centrifugation, the pellet (i.e. isolated 
mitochondria) was washed with isolation buffer 2 times and then resuspended in isolation 
buffer with a protease inhibitor cocktail (i.e. AEBSF, bestatin, E-64, pepstatin A and 
phosphoramidon) to prevent protein degradation (Thermo-Fisher Scientific Inc.).  The 
pellet was then stored at -80 °C until further analysis.  Protein concentration (Western 
blot; Bio-Rad Laboratories Inc., Hercules, CA) and mitochondrial identification 
(bicinchoninic acid [BCA] protein assay) were assessed (Supplemental Table S2.1).  The 
purpose of the BCA is to adjust the tocopherol concentration in the isolated 
mitochondrial fraction.  Mitochondrial integrity identification was performed using a 
primary antibody COX-4 (Novus Biological Co., Littleton, CO) and a secondary antibody 
anti-rabbit IgG HRP (horseradish peroxidase)-linked (Cell Signaling Technology, Inc., 
Danvers, MA).  The protein concentration is presented in Supplemental Table S2.1. 
Confirmation of Plasma Membrane and Mitochondrial Membrane Separation   
The assumption that tocopherol is mainly located in the cell membrane (e.g. 
plasma membrane or mitochondrial membrane) due to its chemical structure (Li and May, 
2003).  To confirm that the measured tocopherol isoforms are only from mitochondrial 
membrane and not from plasma membrane, the following experiment was developed 
(Figure 2.1).  Briefly, from the tissue homogenate, 3 centrifugation products were 
collected: 1) total pellet 12,000 × g (i.e. cell plasma membrane + isolated mitochondria), 
2) 1,000 × g pellet (i.e. cell plasma membrane) and 3) 12,000 × g pellet (i.e. isolated 




cell plasma membrane) and COX-4 (antibody for isolated mitochondria) were selected.  
The secondary antibody anti-rabbit IgG HRP-linked and anti-mouse IgG HRP-linked 
were then used.  Western-blot was then run on the 3 centrifugation products to identify 
the separation between cell plasma membrane and mitochondrial membrane for the 
mitochondrial isolation procedure. 
Isolated Mitochondrial Tocopherol Isoform Analysis 
Isolated mitochondrial fraction solutions were transferred to a 15-mL glass tube 
with Teflon-lined screw caps.  Samples were cold-saponified overnight at 4 °C with 0.4 
mL of 10 % pyrogallol in ethanol and 0.8 mL of 40 % potassium hydroxide in methanol.  
Samples were neutralized with HCl and then extracted 3 times with 5 mL of 80:20 
(hexane:THF [tetrahydrofuran]) Samples were then washed 2 times with water, then 
dried the in a speed-vacuum.  The dried pellet was then dissolved in 0.25 mL of hexane 
containing tocopherols (α-, β-, δ-, and γ-isoforms; i.e. internal control), then 20 µL of 
resuspended sample were injected into the HPLC system as described above. 
RNA Isolation and cDNA Synthesis  
Approximately 30 mg of tissue (i.e. liver, mammary gland and muscle) were used 
for the RNA isolation process.  Total RNA was extracted using the Trizol (Thermo-
Fisher Scientific Inc.) and OMEGA-E.Z.N.A. Total RNA kit (Omega Bio-tek, Inc., 
Norcross, GA) according to the manufacturer’s instructions.  Genomic DNA was 
removed with a DNAase I enzyme.  The RNA concentration was measured using the 
NanoVue Plus (GE Healthcare, Piscataway, NJ).  The purity of extracted RNA was 
calculated by absorbance ratio of 260/280 measured using a NanoVue Plus (GE 




µL) using the iScript cDNA Synthesis Kit (Bio-Rad Laboratories Inc.) and following the 
manufacturer’s protocol.  Integrity of RNA was measured with a Experion bioanalyzer 
(Bio-Rad Laboratories Inc.) average RNA quality indicator number (RQI) was 7.20 ± 
1.50.  The reaction contained 4 μL of 5X reaction mix (blend of oligo [dT] and random 
hexamer primers) optimized for production of targets <1 kb in length, 1 μL of reverse 
transcriptase (RNase H+), and variable amounts of RNA template and nuclease-free 
water in a 20-μL reaction volume.  The reaction was performed in a T100 Thermal cycler 
(Bio-Rad Laboratories Inc.) with a program of 25 °C for 5 min, 42 °C for 30 min, and 
85 °C for 5 min. 
Primer Selection and Evaluation 
Primer selection and efficiency curves were made following Garcia et al. (2015).  
Briefly, primers were selected from previous publications (Supplemental Table S2.2).   
Candidate primers were screened to verify proper sequence with the most updated 
FASTA sequence for corresponding accession number for Bos taurus with prefix NM_ 
(messenger RNA) preferred.   Lyophilized primers (~25 nM DNA oligo, with a standard 
desalting purification method) were obtained from Integrated DNA Technologies 
(Coralville, IA).  Primers were reconstituted with molecular grade water (G-Biosciences, 
St. Louis, MO).  Specificity of primers was verified with a melting curve step included in 
the qPCR assay as described below.  The efficiency of primers was verified by a 6-point 
serial dilution curve (1:4).  Efficiency values ranged from 0.88 to 1.08 with an average 
value of 0.98 and an average R2 of 0.99 (Supplemental Table S2.3).  




Quantitative PCR was performed using SYBR green dye (PerfeCta SYBR Green 
fast mix) from Quanta Biosciences Inc. (Gaithersburg, MD).   Briefly, 4 μL of cDNA 
template (500 ρg of RNA per reaction) was combined with 5 μL of SYBR green dye and 
0.5 μL each of forward and reverse primers (500 nM of each primer per reaction) in a 
skirted 96-well plate (VWR International, Philadelphia, PA).  All samples were run in 
triplicate and were performed in a single plate per a given gene.  The polymerase chain 
reaction (PCR) was performed in a CFX96 optical reaction module (Bio-Rad 
Laboratories Inc.) using the following cycling protocol: initial denaturation at 95 °C for 
30 s, 40 cycles at 95 °C for 5 s and 60 °C for 30 s data collection, annealing and 
extension, and a final step at 95 °C for 10 s before the melting curve.  The melting curve 
step was included to verify the formation of primer dimers and of a single PCR product 
using an incremental temperature of 0.5 °C from 65 °C to 95 °C for 5 s.  A signal melting 
curve was expected to indicate the purity of DNA products.  The qPCR results, given as 
Cq values for each transcript, were analyzed using the 2-ΔΔCq method (Livak and 
Schmittgen, 2001).  Briefly, the Cq of each target gene was calculated and normalized by 
the geometric mean of the 2 selected reference genes (LRP10 and HPCAL1) (Garcia et al., 
2015) to generate ΔCq values.  The ΔCq values without transformation were used for 
statistical analysis. 
Statistical Analysis 
The PROC MIXED procedure of SAS 9.4 (2017) was used for the statistical 
analysis.  The data were analyzed as a complete randomized design.  For the analysis of 
tocopherol accumulation in tissue types (i.e. liver, mammary tissue and triceps brachii 




model included the fixed effect of Tmix supplementation (i.e. Tmix or Control).  
Separation of LSM (least squares mean) and individual comparisons for significant 
effects were performed using PDIFF statement with a TUKEY adjustment in SAS.  The 
model was as follows: 
Yi = μ + Ti + εi 
where Yi is the dependent variable; μ is overall mean; Ti is the fixed effect of Tmix at 
level i (Tmix or Control) and εi is the residual error. 
Within Tmix fed cows only (n = 5), tocopherol accumulation for different 
isoforms was compared across different tissue types after 9 d of feeding, and the data 
were analyzed using a 2 × 3 factorial arrangement with factors including 2 types of 
tocopherol isoforms (i.e. α- or γ-tocopherol) and 3 types of tissues (i.e. liver, mammary 
tissue or muscle).  The fixed variables included tocopherol isoforms and tissue types.  
Separation of LSM and individual comparisons for significant effects were performed 
using the PDIFF statement with a TUKEY adjustment in SAS.  The model was as follows: 
Yij = μ + Ti + Wj + TWij + εij 
where Yij is the dependent variable; μ is overall mean; Ti is the fixed effect of tocopherol 
isoform at level i (α-, β-, γ-, or δ-tocopherol); Wj is the fixed effect of tissue type at level 
j (liver, mammary or muscle);  TWij is the interaction of tocopherol isoform × tissue type, 
and εii is the residual error. 
Within Tmix fed cows only (n = 5), the tocopherol accumulation for different 
isoforms was compared across different types of tissue mitochondria after 9 d of feeding, 
and the data were analyzed using a 2 × 2 factorial arrangement with factors including 2 




(i.e. liver mitochondria or mammary tissue mitochondria).  The fixed variables included 
tocopherol isoform and tissue mitochondrial type.  Separation of LSM and individual 
comparisons for significant effects were performed using the PDIFF statement with a 
TUKEY adjustment in SAS.  The model was as follows: 
Yij = μ + Ti + Mj + TMij + εij 
where Yij is the dependent variable; μ is overall mean; Ti is the fixed effect of tocopherol 
isoform at level i (α-, β-, γ-, or δ-tocopherol); Mj is the fixed effect of mitochondria type 
at level j (liver, mammary or muscle); TMij is the interaction of tocopherol isoform × 
mitochondria type, and εij is the residual error. 
Within Tmix fed cows only (n = 5), the accumulation ratio of α- to γ-tocopherol 
was compared across different sample source (i.e. tissue vs. mitochondrial fraction) and 
tissue type (i.e. liver vs. mammary tissue), the ratio of the concentration of α- to γ-
tocopherol were calculated for liver and mammary tissues, and liver and mammary tissue 
mitochondria.  The calculation was as follows: 
Ratio = (α-tocopherol concentration) / (γ-tocopherol concentration) 
Then the calculated ratios were analyzed using a 2 × 2 factorial arrangement with 
factors including 2 sources of the sample (i.e. tissue or mitochondrial fraction) and 2 
types of tissue (i.e. liver or mammary tissue).  The fixed variables included sample 
sources and tissue types.  Separation of LSM and individual comparisons for significant 
effects were performed using the PDIFF statement with a TUKEY adjustment in SAS.  
The model was as follows: 




where Yij is the dependent variable; μ is overall mean; Ti is the fixed effect of sample 
source at level i (tissue or mitochondria); Mj is the fixed effect of tissue type at level j 
(liver, mammary or muscle); TMij is the interaction of sample source × tissue type, and εij 
is the residual error. 
Within Tmix fed cows only (n = 5), the accumulation ratio of tocopherol in 
mitochondrial fraction was compared to tocopherol in tissue across different tissue type 
and tocopherol isoform, the ratio of the concentration of tocopherol  in mitochondria to 
tissue was calculated for α- and γ-tocopherol isoforms in liver and mammary tissue types 
respectively.  The calculation was as follows: 
Ratio = (mitochondrial tocopherol concentration) / (tissue tocopherol concentration) 
Then the calculated ratios were analyzed using a 2 × 2 factorial arrangement with 
factors including 2 types of tocopherol isoforms (i.e. α- or γ-tocopherol) and 2 types of 
tissue (i.e. liver or mammary tissue).  The fixed variables included tissue type and tissue 
tocopherol isoform.  Separation of LSM and individual comparisons for significant 
effects were performed using the PDIFF statement with a TUKEY adjustment in SAS.  
The model was as follows: 
Yij = μ + Ti + Sj + TSij + εij 
where Yij is the dependent variable; μ is overall mean; Ti is the fixed effect of tocopherol 
isoform at level i (α-, β-, γ-, or δ-tocopherol); Sj is the fixed effect of tissue type at level j 
(liver, mammary or muscle); TSij is the interaction of tocopherol isoform × tissue type, 
and εij is the residual error. 
For all models, the degrees of freedom were estimated with the Kenward-Roger 




standard error of the mean (SEM).  Statistical differences were declared as significant and 
highly significant at P ≤ 0.05 and P ≤ 0.01, respectively.  Trends towards significance are 
discussed at 0.05 < P < 0.10.  For gene analysis, fold-change values were calculated 
according to (Livak and Schmittgen, 2001).  Briefly, LSM (ΔCq) of a factor of interest 
(Tmix) was subtracted from the LSM (ΔCq) of other referential factor (Control) to 
generate the ΔΔCq value, which was linearized to a fold-change (FC) value with the 
formula 2-ΔΔCq. 
RESULTS 
Tocopherol Isoforms Accumulation in Bovine Tissues 
In liver, compared with the Control group, concentrations of α-tocopherol were 
decreased (18.92 vs. 13.72 µg/g tissue; P=0.03; Figure 2.2A) and concentrations of γ-
tocopherol were increased (0.84 vs. 2.82 µg/g tissues; P<0.01; Figure 2.2B) after 9 d of 
Tmix feeding.  In mammary tissue, compared with the Control group, concentrations of 
α-tocopherol were not altered (3.57 vs. 4.05 µg/g tissues; P=0.79; Figure 2.2C) and 
concentrations of γ-tocopherol were increased (0.22 vs. 0.97 µg/g tissues; P=0.04; Figure 
2.1D) after 9 d of Tmix feeding.  In muscle, compared to the Control group, 
concentrations of α-tocopherol tended to decrease (5.95 vs. 5.10 µg/g tissue; P=0.09; 
Figure 2.2E) and concentrations of γ-tocopherol increased (0.40 vs. 0.67 µg/g tissue; 
P<0.01; Figure 2.2F) after Tmix feeding.  Limited β- and δ-tocopherol (<0.1 µg/g tissue) 
concentrations were detected in the liver, mammary gland, and triceps brachii muscle in 
the Control and Tmix groups after 9 d of feeding. 




In the liver (Figure 2.3A), the total pellet fraction showed strong Na/K ATPase 
and COX-4 protein bands by Western blotting.  The 1,000 × g centrifugation fraction 
showed strong Na/K ATPase and weak COX-4 protein bands.  The mitochondrial 
fraction showed moderate Na/K ATPase and strong COX-4 protein bands.  In the 
mammary tissue (Figure 2.3B), the total pellet fraction showed moderate Na/K ATPase 
and strong COX-4 protein bands.  The 1,000 × g centrifugation fraction showed moderate 
Na/K ATPase and COX-4 protein bands.  The mitochondrial fraction showed moderate 
Na/K ATPase and strong COX-4 protein bands.    
Tocopherol Isoforms Accumulation in Bovine Tissue Mitochondria 
Compared to the Control group, concentrations of α-tocopherol were not altered 
(0.12 vs. 0.13 µg/mg protein; P=0.78; Figure 2.4A) and concentrations of γ-tocopherol 
were increased (0.008 vs. 0.03 µg/mg protein; P=0.01; Figure 2.4B) in liver mitochondria 
of Tmix-fed cows. Very low and stable (<0.01 µg/mg protein) amounts of β- and δ-
tocopherol were detected in the liver of the Control and Tmix groups after 9 d of feeding. 
Accumulation Patterns of Tocopherol Isoforms in Bovine Tissues and Mitochondrial 
Fraction 
Within the Tmix group only, the accumulation ratio of α-tocopherol to γ-
tocopherol was lower in the mitochondrial fraction compared to tissue (3.73 vs. 4.69; 
P<0.01; Figure 2.5A).  Regardless of sample source (i.e. tissue and mitochondrial 
fraction), this ratio was not different in liver vs. the mammary tissue (4.18 vs. 3.86; 
P=0.45; Figure 2.5B).  The ratio of tocopherol in the mitochondrial fraction to tocopherol 
in tissues were not statistically different for α- and γ-tocopherol (10.86 vs. 16.04; P=0.15; 




The interaction of tocopherol isoform × tissue was detected (P <0.01).  Alpha-tocopherol 
was higher compared with γ-tocopherol in three different types of tissue (Figure 2.7).  
Liver accumulated α- and γ-tocopherol more compared to muscle and mammary tissues 
(Figure 2.7).  Mammary tissue and muscle accumulated tocopherol at similar levels after 
Tmix feeding.  In the mitochondria, the liver accumulated more tocopherol compared 
with the mammary tissue (0.08 vs. 0.04 µg/mg protein; P=0.02; Figure 2.8A).  Alpha-
tocopherol accumulated at a higher level in mitochondria compared with γ-tocopherol 
(0.10 vs. 0.02 µg/mg protein, respectively; P<0.01; Figure 2.8B) after Tmix feeding.     
The Effect of Tmix on Gene Expression in Bovine Tissues 
The effects of Tmix on gene expression in bovine tissues are shown in Table 2.2.  
In the liver, Tmix increased the expression of TTPA (1.96 FC, P<0.05) coding for α –TTP 
in dairy cattle (Supplemental Table S2.4).  Tmix decreased the expression of NR1I3 (0.71 
FC, P<0.05) coding for a member of transcription factors involved in tocopherol 
metabolism.  In addition, Tmix tended to decrease the expression of RXRα (0.71 FC, 
P=0.09) and decreased the expression of RXRβ (0.68 FC, P=0.01) coding for 
transcription factors involved in tocopherol metabolism.  Tmix did not alter the 
expression of CYP4F2 coding for an enzyme involved in tocopherol metabolism.  Tmix 
did not alter the expression of NR1I2 coding for a transcription factor involved in 
tocopherol metabolism with RXRα and RXRβ.  Tmix did not alter the expression of 
NFKB1 coding for inflammatory reaction or SEC14L2 coding for a tocopherol binding 
protein involved in tocopherol incorporation. 
In the mammary tissue, Tmix did not alter the expression of genes (PPARG, 




incorporation and metabolism.  Tmix did not alter the expression of NFKB1 coding for 
inflammatory reaction.  In muscle tissue, Tmix did not alter the expression of genes 
RXRα, RXRβ, or NFKB1. 
DISCUSSION 
Results showed that Tmix increased the γ-tocopherol concentration in bovine 
tissues (i.e. liver, mammary gland and triceps brachii muscle) and in liver mitochondria.  
Regardless of sample source (i.e. tissues or mitochondria), the concentrations of α-
tocopherol were higher than γ-tocopherol after 9 d of Tmix feeding in dairy cattle.  
Regardless of tocopherol isoforms (i.e. mainly α- or γ-tocopherol), the liver showed the 
highest capacity for storing tocopherol compared to other tissues (i.e. mammary tissue or 
muscle) in dairy cattle.  Very limited β- and δ-tocopherol were detected in tissues or 
tissue mitochondria in dairy cattle after Tmix supplementation.  Tocopherol 
concentrations were more marked in the mitochondrial fraction compared to tissues.  
Furthermore, Tmix altered the expression of genes involved in tocopherol transport and 
metabolism in the liver, but not in the mammary gland and muscle. 
Tmix Increased the Concentration of γ-but not α-Tocopherol in Bovine Tissues and 
Tissue Mitochondria 
Tmix increased the concentration of γ-tocopherol in bovine tissues (i.e. liver, 
mammary tissue, and muscle) after a short-term Tmix supplementation.  Previous study 
demonstrated that pure α-tocopherol supplementation increased the concentration of α-
tocopherol in plasma and tissues in dairy cattle (Politis, 2012).  However, very limited 
data are available regarding the concentration of non-α-tocopherol isoforms in dairy 




considered to have the highest bioavailability in the body due to its preferred 
incorporation in the liver and stability in blood when compared with other isoforms 
(Brigelius-Flohe and Traber, 1999).  However, as an antioxidant, non-α-tocopherol 
isoforms (i.e. β-, γ- or δ-) play a more predominate role against nitrative stress than α-
tocopherol (Wolf, 1997).  In addition, γ-tocopherol is the most enriched tocopherol 
isoform in plants compared to other isoforms (Jiang et al., 2001).  Therefore, non-α-
tocopherol should receive as much attention as α-tocopherol regarding bioaccumulation 
in animals.  This study investigated the accumulation of all four tocopherol isoforms (i.e. 
α- , β-, γ- or δ) after supplementing Tmix in multiple bovine tissues (i.e. liver, mammary 
gland and muscle), while previous studies mainly focused on α-tocopherol in liver tissue 
(Charmley et al., 1992; Debbie et al., 2010). 
Compared to γ-tocopherol, Tmix did not alter the concentration of α-tocopherol in 
bovine tissues, while it decreased the concentration of α-tocopherol in the liver after 9 d 
of feeding.  The partial explanations of these results include the Tmix contained very low 
amounts of α-tocopherol isoforms and/or animals could have a potential variation of α-
tocopherol concentration in the liver.  Regardless of the reduced α-tocopherol 
concentrations after feeding compared to the increased concentrations in liver in previous 
studies, the present study showed similar results regarding the levels of α-tocopherol in 
the liver (~13-18 µg/g tissues) (Charmley et al., 1992; Eicher et al., 1997).  The lack of a 
response in α-tocopherol to Tmix in the mammary gland and muscle tissues is similar to 
the results of others (Eicher et al., 1997).  Regardless of tissue differences, α-tocopherol 
showed higher concentrations compared with γ-tocopherol.  Reasons could be the high 




binding protein reacting with α-tocopherol compared with other non-α-tocopherols 
(Stocker and Azzi, 2000).  Even though Tmix contained a limited amount of α-tocopherol 
compared to other tocopherol isoforms (e.g. γ-tocopherol), the basal diet still contained 
high amounts of α-tocopherol compared to the Tmix which contributed the major source 
of α-isoform in the tissues.  Tocopherol will be absorbed first by the liver after small 
intestinal absorption (Rigotti, 2007).  In the liver, TTPA and SEC14L2 play important 
roles in the incorporation of tocopherol.  Among the four isoforms (i.e. α-, β-, γ- and δ-), 
the binding proteins showed higher affinity for α-isoform compared with other non-α-
tocopherol isoforms, which might partly explain the high concentration of α-tocopherol 
in dairy cattle. 
Mitochondria are cell organelles that are vulnerable to stress and may be damaged 
either by reactive oxygen or nitrogen species during the stress response (Finkel and 
Holbrook, 2000).  An optimal amount of tocopherol in the mitochondria is needed to 
fight against stresses.  The present results showed that Tmix increased the concentration 
of γ-tocopherol, but did not alter the concentration of α-tocopherol in liver mitochondria.  
Previous study has shown that pure α-tocopherol supplementation increased the 
concentration of the α-isoform in liver mitochondria (Lauridsen and Jensen, 2012).  
Based on the results of the separation of plasma membrane and mitochondrial membrane 
in the liver, one might conclude that the detected α- and γ-tocopherols were most likely 
associated with the mitochondrial membrane, based on the assumption that tocopherol  
located in membrane structure is due to its lipid-soluble property (Wang and Quinn, 
1999).  The tocopherol concentration was also measured in the isolated mammary gland 




S2.1).  Due to the limited amounts of α- and γ-tocopherol in the mammary gland in the 
Control group, no statistical comparison of isoforms between Control and Tmix could be 
made.  Within the Tmix group, very low α- and γ-tocopherol concentrations were 
detected in mammary gland mitochondria.  This suggests that tocopherols could be 
incorporated more readily into the liver than the mammary gland mitochondrial fraction. 
Tocopherol might be detectable in mammary gland tissues as supported by the 
tissue data.  Beta- and δ-tocopherol isoforms were detected in tissues and mitochondria at 
very low concentrations indicating that the liver or small intestine might have very 
limited capability to absorb these two isoforms.  Another possible explanation could be 
β- and δ-tocopherol were metabolized too rapidly to be detected in the samples.  Gut 
samples will need to be collected to investigate the fate of β- and δ-tocopherol in the 
future.   Overall, the liver mitochondria showed higher tocopherol accumulation than the 
mammary gland mitochondria.  Alpha-tocopherol accumulated more than γ-tocopherol in 
mitochondrial fractions (i.e. liver and mammary tissues).  
The ratio of Tocopherol Isoforms (α- and γ-Isoform) Accumulated in Tissue and 
Mitochondria  
The ratio of α-: γ-tocopherol was lower in the mitochondrial fraction compared to 
tissues, which might indicate γ-tocopherol accumulated more into the mitochondrial 
fraction than into tissues compared with α-tocopherol.  Previous studies have 
demonstrated the concentration of α-tocopherol in the mitochondrial fraction (Li and May, 
2003; Traber et al., 2007).  However, no available data showed the ratio of different 
tocopherol isoforms in tissue and mitochondrial fractions.  For γ-tocopherol, the ratio of 




tocopherol, indicating that γ-tocopherol tended to accumulate more in the mitochondrial 
fraction than in tissues. 
Regardless of tocopherol isoform, the liver and mammary gland showed similar 
ratios of tocopherol accumulation in the mitochondrial fraction relative to total tissue 
accumulation (Figures 2.5B and 2.6B).  The ratio of tocopherol in mitochondrial 
fraction:tissues is about 10 -15 µg/mg (Figures 2.6A and 2.6B), suggesting that more 
tocopherol was accumulated and detected in the mitochondrial fraction than in tissues.  
Tmix Altered the Expression of Genes Involved in Tocopherol Transport and 
Metabolism in the Liver but not in the Mammary Gland and Muscle Tissues.  
Tmix increased the mRNA expression of TTPA (Table 2.2) in the liver which is 
consistent with previous studies in humans (Traber, 1996; Leonard et al., 2002).  The α-
TTP has been identified as the first protein involved in tocopherol transportation in 
animals and is mainly expressed in the liver (Arita et al., 1997).  It recognizes all four 
tocopherol isoforms, however, it has preferred affinity to α- than other non-α-tocopherols 
(Yunsook, et al., 2007).  This protein is also involved in maintaining tocopherol levels in 
plasma in animals by absorbing tocopherol into the liver.  Once in the liver, tocopherol is 
assembled with lipoproteins (e.g. HDL or other lipids) and then secreted back into 
circulation system as lipid proteins complex (Drevon, 1991).  Therefore, one should 
expect the increased expression of TTPA after tocopherol feeding, which is consistent 
with the present data.  Compared to the increase in TTPA, the expression of SEC14L2 
was not altered by Tmix feeding.  The gene of SEC14L2 encodes for the α-tocopherol 




of change in expression of SEC14L2 might be partly associated with other non-α-
tocopherols (e.g. β-, δ-, and γ-tocopherol) that exist in the liver.   
Contrary to previous study, Tmix decreased the expression of NR1I3 (i.e. CAR), 
RXRα and RXRβ, coding for nuclear receptors involved in tocopherol metabolism.  Tmix 
did not alter the expression of NR1I2 (i.e. PXR) in the liver.  A previous study 
demonstrated that tocopherols are able to bind with PXR or CAR where they then bind 
with RXRα or RXRβ to initiate the metabolism of tocopherol to carboxyethyl-
hydroxychromans (Traber, 2004).  The current results contradict those of Traber (2004), 
and it may be partly attributed to the mixed tocopherol isoform supplementation or the 
sample collection immediately following the feeding trial.  In this study, Tmix contains 
all four isoforms instead of examining only pure α- or γ-tocopherol as in Azzi et al. 
(2004).  The interaction of β- or δ-tocopherol with α- or γ-tocopherol might contribute to 
the observed results.  In addition, samples were collected immediately after the 
completion of the Tmix feeding trial period.  The interval of time was limited so that the 
metabolism (i.e. the expression of genes in tocopherol metabolism) might not be 
detectable in liver.  Decreased expression of genes associated with tocopherol 
metabolism (e.g. NR1I3, RXRα or RXRβ) might enable animals to maintain tocopherol 
levels.  Tmix did not alter the expression of CYP4F2, coding for cytochrome P450 
protein involved in tocopherol metabolism phase I.  This might be associated with the 
decreased mRNA expression of PXR, NR1I3 and RXR (upstream regulators of CYP4F2).  
Besides the liver, Tmix showed minimal effects on the expression of genes involved in 





This study was the first to measure the distribution of four tocopherol isoforms 
(i.e. α-, β-, δ-, and γ-isoform) in multiple tissues (i.e. liver, mammary gland and muscle) 
and tissue sources (i.e. mitochondria in the liver and mammary gland) in dairy cattle.  
The results indicated that short-term (~9 d) Tmix supplementation increased γ-tocopherol 
concentrations but did not increase the α-tocopherol concentration in three different types 
of tissues (i.e. liver, mammary gland and muscle) and liver mitochondria.  Beta- and δ-
tocopherol were detected in tissues and mitochondria at very low concentrations 
indicating that the liver or the small intestine might have very limited capability to absorb 
these two isoforms.  In dairy cattle, γ-tocopherol tended to accumulate more into the 
mitochondrial fraction compared with tissue.  Because limited amounts of β- and δ-
tocopherol were detected, α- and γ-tocopherol might play predominate roles in dairy 
cattle as vitamin supplements.  In the end, the present data provide additional information 
regarding the pattern of tocopherol isoforms in dairy cattle in the major tissues (i.e. liver) 
and mitochondria for the development of management tools regarding tocopherol 
supplementation in agricultural animal species. 
REFERENCES 
Anwar, K., J. Iqbal, and M. M. Hussain. 2007.  Mechanisms involved in vitamin E 
transport by primary enterocytes and in vivo absorption. J. Lipid Res. 48: 2028-2038.  
 
Azzi, A., R. Gysin, P. Kempna, A. Munteanu, Y. Negis, L. Villacorta, T. Visarius, and J.-
M. Zingg. 2004. Vitamin E mediates cell signaling and regulation of gene expression. 
Ann. N. Y. Acad. Sci. 1031:86-95. 
 
Arita, M., K. Nomura, H. Arai, and K. Inoue. 1997. Alpha-tocopherol transfer protein 
stimulates the secretion of alpha-tocopherol from a cultured liver cell line through a 





Atkinson, J., R. F. Epand, and R. M. Epand. 2008. Tocopherols and tocotrienols in 
membranes: A critical review. Free Radic. Biol. Med. 44:739-764. 
 
Blatt, D. H., S. W. Leonard, and M. G. Traber. 2001. Vitamin e kinetics and the function 
of tocopherol regulatory proteins. Nutrition. 17:799-805. 
Brigelius-Flohe, R. and M. G. Traber. 1999. Vitamin E: function and metabolism. The 
FASEB J. 13:1145-1155. 
 
Charmley, E., N. Hidiroglou, L. Ochoa, L. R. McDowell, and M. Hidiroglou. 1992. 
Plasma and hepatic alpha-tocopherol in cattle following oral or intramuscular 
supplementation. J. Dairy Sci. 75:804-810. 
 
Drevon, C. 1991. Absorption, transport and metabolism of vitamin E. Free Radic. Res. 
Commun. 14:229-46. 
 
Dutta-Roy, A. K., M. J. Gordon, F. M. Campbell, G. G. Duthie, and W. P. T. James. 1994. 
Vitamin E requirements, transport, and metabolism: Role of alpha-tocopherol-binding 
proteins. J. Nutr. Biochem. 5:562-570. 
 
Eicher, S. D., J. L. Morrill, and J. Velazco. 1997. Bioavailability of alpha-tocopherol fed 
with retinol and relative bioavailability of D-alpha-Tocopherol or DL-alpha-tocopherol 
acetate. J. Dairy Sci. 80:393-399. 
 
Elsasser, T.H., S. Kahl, K.M. Lebold, M.G. Traber, J. Shaffer, C. Li, and S. Block. 2013. 
Short-term alpha-or gamma-delta-enriched tocopherol oil supplementation differentially 
effects the expression of proinflammatory mediators: selective impacts on characteristics 
of protein tyrosine nitration in vivo. Vet. Sci. Develop. 3: 20-38. 
Franke, A. A., S. P. Murphy, R. Lacey, and L. J. Custer. 2007. Tocopherol and 
tocotrienol levels of foods consumed in Hawaii. J. Agric. Food Chem .55:769-778. 
 
Ferguson, J. D., D. T. Galligan, and N. Thomsen. 1994. Principal descriptors of body 
condition score in Holstein cows. J. Dairy Sci.77:2695-2703. 
 
Finkel, T. and N. J. Holbrook. 2000. Oxidants, oxidative stress and the biology of ageing. 
Nature. 408:239-247. 
 
Garcia, M., T. H. Elsasser, Y. Qu, X. Zhu, and K. M. Moyes. 2015. Glucose 
supplementation has minimal effects on blood neutrophil function and gene expression in 
vitro. J. Dairy Sci. 98:6139-6150. 
 
Gruber, J., S. Fong, C. B. Chen, S. Yoong, G. Pastorin, S. Schaffer, I. Cheah, and B. 
Halliwell. 2013. Mitochondria-targeted antioxidants and metabolic modulators as 





Hidiroglou, M., M. Ivan, and N. Hidiroglou. 1990. Kinetics of intravenously 
administered vitamin E in sheep and its biliary excretion. Ann. Rech. Vet. 8:228-232. 
 
Jarvinen, R. and A. T. Erkkila. 2016. Tocopherols: physiology and health effects. PP. 
303-308 in Encyclopedia of Food and Health. Academic Press, Oxford. 
 
Jiang, Q., S. Christen, M. K. Shigenage, and B. N. Ames. 2001. Gamma-tocopherol, the 
major form of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 
74:714-722. 
Kaempf-Rotzoll, D. E., M. G. Traber, and H. Arai. 2003. Vitamin E and transfer proteins.  
Lipidology. 14:249-254. 
Kagan, V. E., J. Jiang, H. Bayir, and D. A. Stoyanovsky. 2007. Targeting nitroxides to 
mitochondria: location, location, location, and concentration: highlight commentary on 
mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage 
and apoptosis: Role of mitochondrial superoxide. Free Radic. Biol. Med. 43:348-350. 
 
Lauridsen, C. and S. K. Jensen. 2012. Alpha-Tocopherol incorporation in mitochondria 
and microsomes upon supranutritional vitamin E supplementation. Genes Nutr. 7:475-
482. 
 
Leonard, S. W., Y. Terasawa, R. V. Farese Jr, and M. G. Traber. 2002. Incorporation of 
deuterated RRR- or all-rac-alpha-tocopherol in plasma and tissues of alpha tocopherol 
transfer protein-null mice. Am. J. Clin. Nutr. 75:555-560. 
 
Li, X. and J. M. May. 2003. Location and recycling of mitochondrial alpha-tocopherol. 
Mitochondrion. 3:29-38. 
 
Livak, K. J. and T. D. Schmittgen. 2001. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2deltadeltaCT method. Methods. 25:402-408. 
 
Meier, R., T. Tomizaki, C. Schulze-Briese, U. Baumann, and A. Stocker. 2003. The 
molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer 
protein. J. Mol. Biol. 331:725-734. 
 
Mustacich, D. J., S. W. Leonard, N. K. Patel, and M. G. Traber. 2010. Alpha-tocopherol 
beta-oxidation localized to rat liver mitochondria. Free Radic. Biol. Med. 48:73-81. 
 
Mustacich, D. J., A. T. Vo, V. D. Elias, K. Payne, L. Sullivan, S. W. Leonard, and M. G. 
Traber. 2007. Regulatory mechanisms to control tissue alpha-tocopherol. Free Radic. 
Biol. Med. 43:610-618. 
 
National Research Council. 2001. Nutrient requirements of dairy cattle. 7th rev.ed. 





Politis, I. 2012. Reevaluation of vitamin E supplementation of dairy cows: bioavailability, 
animal health and milk quality. Animal. 6:1427-1434. 
 
Rigotti, A. 2007. Absorption, transport, and tissue delivery of vitamin E. Mol. Aspects 
Med. 28:423-436. 
 
Stocker, A. and A. Azzi. 2000. Tocopherol-binding proteins: their function and 
physiological significance. Antioxid. Redox Signal. 2:397-404. 
 
Traber, M. G. H. S. 1996. Vitamin E in humans: demand and delivery. Ann. Rev. Nutr. 
16: 321-347. 
 
Traber, M. G. 2004. Vitamin E, nuclear receptors and xenobiotic metabolism. Arch. 
Biochem. Biophys. 423:6-11. 
 
Traber, M. G. 2007. Vitamin E regulatory mechanisms. Ann. Rev. Nutr. 27: 347-62.  
 
Wang, X. and P. J. Quinn. 1999. Vitamin E and its function in membranes. Prog. Lipid 
Res. 38:309-336. 
Wolf, G. 1997. Gamma-tocopherol: an efficient protector of lipids against nitric oxide-
initiated peroxidative damage. Nutr. Rev. 55:376-378. 
 
Yapici, N. B., S. Mandalapu, K. Michael Gibson, and L. Bi. 2015. Targeted fluorescent 
probes for detection of oxidative stress in the mitochondria. Bioorg. Med. Chem. Lett. 
25:3476-3480. 
 
Yunsook, L., and M. G. Traber. 2007. Alpha-tocopherol transfer protein: insights from 
alpha-tocopherol transfer protein knockout mice. Nutr. Res. Pract. 4: 247-253. 







Table 2.1. Ingredient and nutrient composition (DM basis) of the total mixed ration1 and Isoform 
concentrations in the experimental diets fed for 9 days. 
Item Amount, % of dietary DM 
Ingredient  
Corn silage 31.0 
Alfalfa-wheat silage 8.0 
Cottonseed, whole 4.5 
Citrus pulp, dehydrated 4.5 
Sugar blend2 3.9 
Alfalfa hay 3.6 
Grass hay 3.6 
Grain mix3 39.1 












ME, Mcal/kg of DM 2.5 
VitaminA, kIU/kg of DM 19.7 
VitaminD, kIU/kg of DM 4.9 
VitaminE, IU/kg of DM 16.4 
1The total mixed ration (52.2 % DM) with the following ingredients: corn silage (31.0 %), alfalfa: wheat 
silage (8.0 %), alfalfa hay (3.6 %), grass hay (3.6 %), whole cottonseed (4.5 %), dehydrated citrus pulp 
(4.5), sugar blend (3.9 %), and lactation grain mix (39.1 %). On a DM basis, the ration contained17.0% 
crude protein (CP), 18.4 % acid detergent fiber (ADF), 28.1 % neutral detergent fiber (NDF), 3.2% lignin, 
6.0 % ether extract, 0.9 % calcium (Ca), 0.3 % phosphorus (P), 1.2 % potassium (K), 0.5 % magnesium 
(Mg), and 2.49 megacalorie (Mcal) of ME/kg.. 
2The sugar blend (3.9 % DM) with the following ingredients: crude protein (1.0 %), crude fat (0.1 %), 
crude fiber (0.1 %), acid detergent fiber (ADF) (0.1 %), calcium (0.75 %), phosphorus (0.1%), cobalt 
(8ppm), copper (138ppm), manganese (345ppm), zinc (690ppm), selenium (8.27ppm), vitamin A 
(3800IU/lb), vitamin D3 (6250IU/lb), vitamin E (125IU/lb), TSI (total sugar as invert) (33.0%), DM (60.0%) 
and moisture (40%). 
3The grain mix (39.1 % DM) with the following ingredients: Corn ground, finely ground (92.0 %), 
AminoPlus (1.24 %), Soybean meal 48 % (1.24 %), Soybean, whole, roasted (1.55 %), Soybean hulls 
(1.17 %), Megalac (0.75 %), LysAAmet (0.39 %), Optigen (0.42 %), Limstone (0.34 %), Salt-white 
(0.21 %), Magnesium oxide (0.17 %), USDA custom dairy min#4 (0.15 %), Potassium-magnesium sulfate 
(0.11%), Sodium bicarbonate (0.08 %), Urea 45 % (0.04 %), MFP Novus (0.04 %), Mepron M85 (0.02 %), 











Table 2.2. Effect of Mixed tocopherol oil supplement (Tmix1) supplementation on the expression of genes 
in bovine tissues: Control ( n = 4) or Tmix (n = 5). Data were analyzed using the 2-ΔΔCt method and 
presented as Fold-Change (Tmix relative to Control). 
 Tmix vs. Control 
FC P-value 
Liver   
CYP4F2 0.96 0.84 
NFKB1 0.81 0.28 
NR1I2 0.81 0.49 
NR1I3 0.71                                              <0.05 
 RXRα  0.71 0.09 
RXRβ 0.68 0.01 
RARα 1.02 0.85 
SEC14L2 0.80 0.16 
TTPA 
 
1.96                                               <0.05 
Mammary   
NFKB1 0.99 0.90 
PPARG 1.33 0.23 
RXRα 0.95 0.72 
RXRβ 1.17 0.16 




Muscle   
NFKB1 0.94 0.84 
RXRα 0.63 0.14 
RXRβ 0.82 0.77 
1Miexed tocopherol oil supplement (Tmix): 300 g of (9 % α-, 1 % β-, 24 % δ-, and 62 % γ-tocopherol) pure 
tocopherol mixed with 22.68 kg of calf grower (Farmers Cooperative Association Inc.), then fed at ~620 







Figure 2.1. Confirmation of plasma membrane and mitochondrial membrane separation in mitochondrial 
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Figure 2.2. Concentrations of α-tocopherol (A) and γ-tocopherol (B) in liver, concentrations of α-
tocopherol (C) and γ-tocopherol (D) in the mammary tissue, and concentrations of α-tocopherol (E) and γ-
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Figure 2.4. Tocopherol isoform concentration in bovine liver mitochondria: Control vs. Tmix (mixed 





Figure 2.5. The ratio of α:γ-tocopherol in either mitochondrial fraction vs. tissue (A) or liver vs. mammary 






Figure 2.6. The ratio of the concentration of tocopherol in mitochondria : tocopherol in tissues for α-
tocopherol vs. γ-tocopherol (A) or the liver vs. the mammary tissue (B) after 9 d of Tmix (mixed 











Figure 2.7. The pattern of tocopherol isoforms across different tissue types after 9 d of Tmix (mixed 








Figure 2.8. The concentration of total tocopherol in the liver or mammary tissue mitochondria (A) or the 






CHAPTER 3: THE DISTRIBUTION OF TOCOPHEROL ISOFORMS IN 
BOVINE MILK AND BLOOD VIA SHORT-TERM MIXED TOCOPHEROL OIL 
SUPPLEMENTATION 
ABSTRACT 
Fed over several weeks, diets supplemented with α-tocopherol will increase α-
tocopherol concentrations in blood and milk.  With new attention being paid to other non-
α isoforms of vitamin E, how supplementation of other tocopherol isoforms affects 
subsequent milk and blood concentrations is poorly understood.  The objective of this 
study was to determine the effect of feeding a mixed tocopherol oil supplement (Tmix) 
and the frequent pattern of change of 4 isoforms (α-, β-, γ-, and δ) of tocopherol in blood 
and milk from lactating dairy cows.  Twelve multiparous Holstein cows in mid-lactation 
were used to evaluate the effect of Tmix feeding (i.e. d 0 v d 7 of feeding).  A subset (n = 
4) were used for the daily measurement.  Furthermore, a subset (n = 2) were used for 
more frequent measurements (every 8 h from d 2 to 5 of Tmix feeding).  Composite milk 
(~25 mL) and whole blood (~15 mL) samples were collected throughout the study.  
Tocopherol isoform concentrations were determined by high-pressure liquid 
chromatography.  Data were analyzed in a complete randomized design with repeated 
measures.  Significance was declared at P ≤ 0.05.  Gamma and α-tocopherols in blood 
increased by d 1 and d 2, respectively, after feeding with peak concentrations achieved by 
d 5 (3.6 ± 0.2 µg /mL for γ- and 14.1± 0.5 µg/mL forα-tocopherol) when compared to d 1 
(0.59 ± 0.2 µg/mL for γ- and 10.0 ± 0.5 µg/mL for α-tocopherol).  In milk, γ- and α-
tocopherol concentrations were elevated by d 2 (0.26 ± 0.04 µg/g) and d 3 (0.72 ± 0.05 




No significant change in blood or milk was detected for the more frequent sampling (i.e. 
every 8 hour for 52 h).  Non-detectable values were obtained for β- and δ-tocopherol in 
blood and milk, respectively.  The data illustrate that ~5 d of Tmix feeding at the level 
used may be sufficient to reach a higher stabilized range of concentrations of the two 
measurable isoforms in milk and blood in the lactating Holstein.  The data established 
that this experimental design is adequate towards the further refinement of experiments 
that will be valuable towards characterizing the kinetics and biological value of α- and γ-
tocopherols.  Additional sampling at the gut level may be informative in determining the 
fate of β- and δ-tocopherol.  
INTRODUCTION 
Vitamin E has been used as a feed supplement for dairy cattle for decades (Baldi, 
2005).  Dietary α-tocopherol acetate or succinate are the synthetic isoforms most 
commonly used in the industry by the National Research Council (NRC, 2001).  Previous 
studies in dairy cattle have shown that 7 µM (i.e. ~3 µg/mL) of vitamin E (α-tocopherol) 
is the average cut-off value in blood, and inadequate vitamin E (α-tocopherol) 
concentration in blood (< 7 µM: ~3 µg/mL) may partially explain the increased risk of 
metabolic and infectious diseases/disorders in dairy cows shortly after calving (Mudron 
et al., 1997; Weiss et al., 1997).  Recent studies also have shown that serum vitamin E 
(i.e. α-tocopherol) depletion (< 7 µM) during the transition from later pregnancy to early 
lactation might contribute to the development of metabolic disorders such as left 
displaced abomasum and retained placenta (Qu et al., 2013; Qu et al., 2014).  Therefore, 
it is essential to maintain the adequate vitamin E level in the blood to support animal 




information of non-α-tocopherol (i.e. β-, δ-, and γ-tocopherol) in blood is available 
compared to the α-isoform in dairy cattle.  Non-α-tocopherols differ from α-tocopherol 
by the number and position of methyl groups on the chromanol ring (Combs and 
McClung, 2017).  The various isoforms play different roles in maintaining animal health.  
Alpha-tocopherol is mainly protective against oxidative stress, while non-α-tocopherols 
are primarily protective against nitrative stress (Cobb and Cole, 2015).  In addition, γ-
tocopherol is the major form of vitamin E in many plant seeds but has drawn little 
attention compared to α-tocopherol (Jiang et al., 2001).  The possible reasons for this lack 
of attention could be the high and persistent concentration of the α-isoform detected in 
animals, and that non-α-tocopherols are metalized too quickly to be detectable in blood 
(Traber et al., 1999).  However, to our current knowledge, no available data show the 
hourly and daily changes of non-α-tocopherol concentrations in blood after feeding 
tocopherol supplements to indicate their availability. 
Achieving a sufficient concentration of tocopherol (i.e. α-, β-, δ-, and γ-tocopherol) 
in milk is also desirable for dairy cattle production.  Previous study has shown that 
increasing the concentration of α-tocopherol in milk could help to improve the oxidative 
stability of milk (Weiss and Wyatt, 2003).  In addition, previous study has shown that 
giving dietary α-tocopherol increases its concentration in milk.  Besides keeping 
oxidative stability, adequate tocopherol (i.e. α-, β-, δ-, and γ-tocopherol) concentration is 
also essential to maintain high quality of colostrum (Parrish et al., 1947).  Previous study 
has demonstrated that dietary α-tocopherol helped to protect against mastitis and improve 
milk quality by lowering the somatic cells count (SCC) in bulk tank milk (Hogan et al., 




tocopherol.  Limited information is available regarding non-α-tocopherol (i.e. β-, δ-, and 
γ-tocopherol) in milk.  Therefore, the main objective of this study was to investigate the 
effect of Tmix and the more frequent patterns of changes of all four tocopherol isoform 
concentrations in blood and milk in response to short-term Tmix supplementation.  The 
second objective of this study was to combine the data in blood and milk with the data in 
tissue and mitochondrial fractions (Chapter 2) to construct the dynamic pattern change of 
all four tocopherol isoform concentrations in dairy cattle and provide feeding strategies 
for vitamin E supplementation in agricultural animal species.  The hypotheses are that 
Tmix will increase non-α-tocopherol isoforms (i.e. β-, γ-, and δ-) in blood and milk after 
7 d feeding.  
MATERIALS AND METHODS 
All procedures involving the use of live animals were approved in accordance to 
the regulations and guidelines set forth by the U.S. Department of Agriculture, Beltsville 
(# 15-009), Animal Care and Use Committee and were approved by the Institutional 
Animal Care and Use Committee at the University of Maryland, College Park (# 626721-
1). 
Animals and Treatments 
Twelve multiparous Holstein cows in mid-lactation (179 ± 17 DIM) were used to 
evaluate the effect of Tmix feeding (i.e. d 0 v 7 d of feeding). A subset (n = 4) were used 
for the daily measurement.  Furthermore, a subset (n = 2) were used for a more frequent 
measurement (i.e. every 8 h from 2 to 5 d of Tmix feeding).  None of the cows displayed 
any clinical signs of disease and collectively had an average composite milk SCC of 




with its own feed bunk, had free access to water and were milked twice daily at 0600 h 
and 1800 h.  Cows were fed a TMR ad libitum (Table 2.1).  Cows were fed on average 
22.7 ± 2 kg DM divided into two equal portions with the first allotment put into the feed 
bunk at 0700 and the second at 1400 h.  All cows were fed the Tmix for 7 consecutive 
days.   
Blood and Milk Sample Collection 
Jugular blood was collected from all cows after the morning milking and prior to 
the morning feeding into 15-mL EDTA tubes (Becton Dickinson Vacutainer System, 
Franklin Lakes, NJ).  Plasma was collected from EDTA tubes after centrifugation at 1300 
× g for 15 min at 4 °C and stored in 1.5-mL tubes at -20 °C for future tocopherol isoform 
analysis.  Milk samples (~20 mL) were collected into 25-mL conical tubes (VWR 
International, Philadelphia, PA).  Milk samples were stored at 4 ºC for future tocopherol 
isoform analysis. 
Blood and Milk Tocopherol Isoform Analysis 
For blood samples, 300 µL of plasma was mixed with 300 µL of water containing 
EDTA (10 mg/L) and ascorbic acid (100 mg/L).  Samples were precipitated with 600 µL 
of ethanol containing tocopherol (i.e. α-, β-, δ-, and γ-isoform) as the internal standard 
and extracted 2 times with 2 mL of hexane.  The combined hexane extracts were vacuum 
dried and reconstituted in 100 µL of hexane.  Twenty μL of prepared solutions were 
injected into the HPLC system.  For milk samples, ~ 2 g of milk sample was saponified: 
0.4 mL pyrogallol in ethanol, 1 mL 40 % KOH in methanol at 70 ºC for 45 min.  Samples 
were extracted 3 times with 5 mL of (80 hexane: 20 THF [tetrahydrofuran]), then washed 




0.5 mL of hexane containing tocopherol (i.e. α-, β-, δ-, and γ-isoform) as the internal 
standard.  Twenty μL of prepared solutions were injected into the HPLC system.  
Separation was performed using the ThermoSeparations Products HPLC system 
(Thermo-Fisher Scientific Inc., Pittsburgh, PA) with a Chromegabond Diol column (ES 
Industries, west Berlin, NJ, 3µm, 150 x 4mm), equipped with an FL3000 fluorescence 
detector and a UV2000 programmable UV/visible detector.  The mobile phase was 4 % 
dioxane in hexane pumped at 1.0 mL/min and a run time of 20 min. The UV detector was 
set at 269 nm and the fluorescence detector was set at 290 nm excitations and 340 nm 
emissions. 
Statistical Analysis 
For the effect of Tmix (i.e. 0 and 7 d), the class variable included cow and Tmix 
supplementation.  Cow was used as a random term.  The model included the fixed effect 
of Tmix supplementation as follows: 
Yi = μ + Ti + εi 
where Yi is the dependent variable; μ is overall mean; Ti is the fixed effect of 
Tmix supplementation at level i (α-, β-, γ-, or δ-tocopherol), and εi is the residual error.  
For daily and every 8 h measurements, data were analyzed as repeated-measures-in-time 
ANOVA using PROC MIXED of SAS 9.4 (2017).  The variance-covariance structure of 
repeated measures was modeled using the heterogeneous first-order autoregressive 
variance-covariance matrix based on smallest AIC (akaike information criterion) value.  
For daily measurements only, d 0 was used as a covariate.  The model included the fixed 
effect of sampling time.  The model was as follows: 




where Yi is the dependent variable; μ is overall mean; Si is the fixed effect of  time at 
level i (daily: 0, 1, 2, 3, 4, 5, 6, or 7; hour: 0, 8, 16, 24, 32, 40, 48 or 52h)  and εi is the 
residual error. 
For all models, the degrees of freedom were estimated with the Kenward-Roger 
specification in the model statement.  The data were presented as LSM and largest SEM.  
Statistical differences were declared as significant and highly significant at P ≤ 0.05 and 
P < 0.01, respectively.  Trends towards significance are discussed at 0.05 < P < 0.10. 
RESULTS 
The Effect of Tmix Feeding 
Tmix increased the concentration of α-tocopherol (11.19 vs. 14.89 µg/mL; Figure 
3.1 A), the concentration of γ-tocopherol (0.63 vs. 3.05 µg/mL; Figure 3.1 B), and the 
concentration of total-tocopherol (11.83 vs. 18.01 µg/mL; Figure 3.1 D) after 7 d of Tmix 
feeding in blood plasma.  Even though a very low concentration of β-tocopherol was 
measured, Tmix increased its concentration (0.02 vs. 0.05 µg/mL; Figure 3.1 C) in blood 
after 7 d of feeding.  Feeding of Tmix increased the concentrations of α-tocopherol (0.61 
vs. 0.95 µg/mL; Figure 3.2 A), γ-tocopherol (0.23 vs. 0.56 µg/mL; Figure 3.2 B) and 
total-tocopherol (0.81 vs. 1.53 µg/mL; Figure 3.2 C) in milk after 7 d.  
Daily Measurements of Tocopherol Isoforms  
The concentration of α-tocopherol in blood plasma was increased after Tmix 
feeding and reached peak concentration at d 5 (14.10 µg/mL; Figure 3.3 A) compared to 
d 1 and kept consistent until d 7.  The concentration of γ-tocopherol in blood plasma was 
increased after Tmix feeding and reached to the peak concentration at d 5 (3.60 µg/mL; 




constant until d 7.  The concentration of total-tocopherol (i.e. α- and γ-tocopherol) in 
blood plasma was increased after Tmix feeding and reached peak concentration at d 5 
(17.80 µg/mL; Figure 3.3 C) compared to d 1 and kept constant until d 7.  Limited β- and 
δ-tocopherol were detected in blood plasma.  The concentration of α-tocopherol in milk 
was increased after Tmix feeding and reached peak concentration around d 4 (0.84 
µg/mL; Figure 3.4 A) compared to d 1 and kept constant until d 7.  The concentration of 
γ-tocopherol in milk was increased after Tmix feeding and reached peak concentration 
around d 4 (0.37 µg/mL; Figure 3.4 B) compared to d 1.  At d 7, γ-tocopherol in milk 
showed the numerically highest concentration (0.48 µg/mL; Figure 3.4 B).  The 
concentration of total-tocopherol (i.e. α- and γ-tocopherol) in milk was increased after 
Tmix feeding and reached peak concentration around d 4 (1.21 µg/mL; Figure 3.4 C) 
compared to d 1.  At d 7, total-tocopherol in milk showed the numerically highest 
concentration (1.47 µg/mL; Figure 3.4 C). 
Frequent (every 8h) Measurements of Tocopherol Isoforms 
After 2 d of Tmix feeding, the concentration of α-tocopherol in blood plasma was 
not altered through the 8 sampling time points (Figure 3.5 A).  After 2 d of Tmix feeding, 
the concentration of γ-tocopherol in blood plasma was not altered through the first 3 
sampling time points (i.e. 0, 8 and 16 h), dropped between 16 and 24 h (Figure 3.5 B), 
then remained constant.  Very low β-tocopherol concentration was detected after 2 d of 
Tmix feeding (Figure 3.5 C) and the concentration was not altered through the 8 
sampling time points.  The concentration of total tocopherol (i.e. α-, β- and γ-tocopherol) 




After 2 d of Tmix feeding, the concentration of α-tocopherol in milk was not 
altered through the 5 sampling time points (Figure 3.6 A).  After 2 of Tmix feeding, the 
concentration of γ-tocopherol in milk was not altered through the first 4 sampling time 
points, and the peak concentration was detected at 48 h (0.85 µg/mL; Figure 3.6 B).  
After 2 d of Tmix feeding, the concentration of total-tocopherol in milk was not altered 
through the 5 sampling time points (Figure 3.6 C).  
DISCUSSION 
Tmix Increased α- and γ-Tocopherol Concentrations 
Tmix increased α- and γ-tocopherol concentration after 7 d of Tmix 
supplementation in milk and blood.  Very low and stable concentrations of β-tocopherol 
were detected before and after Tmix feeding.  Non-detectable amounts of δ-tocopherol 
were observed.  Tocopherols (e.g. α- or γ-tocopherol) were detected more in blood than 
milk, which is consistent with previous studies (Charmley et al., 1993; St-Laurent et al., 
1990; Weiss and Wyatt, 2003).  Even though tocopherol concentrations were low in milk, 
the tocopherol concentrations (0.2 ~ 0.95 µg/g milk) were within normal ranges from 
previous studies (0.2 ~ 1.10 µg/g milk) (Weiss and Wyatt, 2003; Meglia et al., 2006).  
This might indicate that Tmix could compensate of γ-tocopherol in milk and blood, also 
reach the animal’s vitamin E supplements requirement, which supported by the daily 
measurements data.  A previous study also measured the concentration of cholesterol in 
the blood to indicate α-tocopherol concentration change in blood (Traber and Jialal, 
2000).  Because cholesterol is primarily in the high density lipoprotein fraction, which is 
need to transport tocopherols (Herdt and Smith, 1996).  In this study, no differences were 




might indicate Tmix did not alter α-tocopherol concentration due to the existence of other 
tocopherol isoforms.   
Tmix Increased the Daily α- and γ-Tocopherol Concentrations 
Previous study has demonstrated that increasing the amount of dietary α-
tocopherol increased its concentration in blood and milk (Lindqvist et al., 2011).  An 
increasing pattern between amount of tocopherol fed and tocopherol concentration in 
blood and milk has been tested (Weiss and Wyatt, 2003).  However, the information of 
other tocopherol isoforms (e.g. γ-tocopherol) and the time pattern changes of tocopherol 
concentrations in milk and blood are still unknown.  The data showed daily increases of 
α- and γ-tocopherol concentration in blood plasma and milk via Tmix supplements.  The 
increasing pattern of γ-tocopherol was more marked compared to α-tocopherol in blood 
especially within the first 2 d of Tmix supplementation.  This difference between α and γ 
might demonstrate that Tmix contributes more γ- than α-tocopherol into the blood.  Prior 
to Tmix feeding, α-tocopherol concentrations were higher compared to γ-tocopherol 
which demonstrates that there was a high level of α-tocopherol accumulation in blood 
before Tmix feeding but not much of γ-tocopherol.  Tmix could significantly increase γ-
tocopherol in blood plasma.   
Combined with the liver data (Chapter 2) one might conclude that during the first 
couple of days (i.e. d 1 – d 4), the peak concentration in blood for tocopherol (i.e. α- and 
γ-tocopherol) concentration was not reached.  This may be partly explained by the rapid 
liver absorption of tocopherol (i.e. α- and γ-tocopherol) initially until peak concentration 
in liver was reached (13.72 and 2.82 µg/g tissues) hence reflecting concentrations in 




(i.e. starting accumulation from liver to blood and other peripheral tissues) and the 
importance of liver in tocopherol transportation in animals (Jañrvinen and Erkkila, 2016).  
Limited quantities of β- and δ-tocopherol were detected in blood and milk in dairy cows.  
Frequent (every 8 h) Measurements did not Alter the α- and γ-Tocopherol 
Concentrations. 
Limited changes of tocopherol isoforms (i.e. α-, β- and γ) were detected in blood 
and milk every 8 h.  The purpose of the every 8 h measurements after 2 d of Tmix 
feeding was to investigate any changes of tocopherol isoforms in milk and blood during 
tocopherol within daily accumulation.  More importantly, I originally expected to detect 
β- or δ-tocopherol concentrations in milk and blood within 1 d.  However, no detectable 
concentration of β- and δ-tocopherol were detected in blood and milk even though δ-
tocopherol was the second highest enrichment tocopherol isoform in the Tmix.  
Combined with tissue data, one might conclude that very limited amounts of β- or δ-
tocopherol passed through the small intestines, the initial site of tocopherol absorption in 
animals or  even though it is assumed that amounts of β- and δ-tocopherol passed through 
the small intestines.  These two tocopherols metabolism processes were too rapid to be 
detected by more frequent sampling (every 8 h starting at 2 d post-feeding).  Therefore, 
additional gut level sampling and short time post feeding sampling might be needed to 
determine the rate of β- or δ-tocopherol in animals.  Besides β- or δ-tocopherol, limited 
changes of α- and γ-tocopherol were detected.  The concentrations of α- and γ-tocopherol 
were consistent with daily measurements to indicate the tocopherol accumulation process 




and 24 h was observed in blood, this difference might partly be associated with animal 
variation instead of a Tmix effect.  
CONCLUSIONS 
Tocopherol isoforms (i.e. α- and γ-tocopherol) start to accumulate after Tmix 
supplementation (i.e. 11.1 vs. 14.8 µg/mL: 0.6 vs. 0.9 µg/g and 0.6 vs. 3.0 µg/mL; 0.2 vs. 
0.5 µg/g) compared to before feeding.  Especially for γ-tocopherol, the Tmix 
compensated for the low concentration of γ-isoform in blood and milk observed prior to 
feeding.  The results indicate that even though Tmix might not mainly contribute α-
isoform , α-tocopherol was elevated in animals via standard ration feeding, which 
partially explained by its absorption preference in liver compared to γ-tocopherol.  Also, 
the data illustrate that ~5 d of Tmix feeding may be sufficient to reach a higher stabilized 
range of concentrations of the two measurable isoforms (i.e. α- and γ-tocopherol) in milk 
and blood in the lactating Holstein dairy cow.  This study establishes that this 
experimental design is adequate towards the further refinement of experiments that will 
be valuable towards characterizing the kinetics and biological value of α- and γ-
tocopherols.  Additional sampling at the gut level may be informative in determining the 
fate of other isoforms (i.e. β- and δ-tocopherol).  
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Figure 3.1.  Tocopherol isoforms measurements of d 0 pre-feeding vs. d 7 post-feeding Tmix (mixed 
tocopherol oil supplement) in bovine blood: (A) α-tocopherol, (B) γ-tocopherol, (C) β-tocopherol and (D) 









   
                                  Days of feeding                                                                           
Figure 3.2.  Tocopherol isoforms measurements of d 0 pre-feeding vs. d 7 post-feeding Tmix (mixed 
tocopherol oil supplement) in bovine milk: (A) α-tocopherol, (B) γ-tocopherol and (C) total-tocopherol (i.e. 










                                                     Days of feeding Tmix 
Figure 3.3. Daily tocopherol isoforms measurements in bovine blood (n=4): (A) α-tocopherol, (B) γ-
tocopherol and (C) total-tocopherol (i.e. α- and γ-tocopherol) via Tmix (mixed tocopherol oil supplement) 







                                               Days of feeding Tmix 
Figure 3.4. Daily tocopherol isoforms measurements in bovine milk (n=4): (A) α-tocopherol, (B) γ-
tocopherol and (C) total-tocopherol (i.e. α- and γ-tocopherol) via Tmix (mixed tocopherol oil supplement) 












Figure 3.5. Frequent pattern of tocopherol isoform measurements in bovine blood (n=2): (A) α-tocopherol, 
(B) γ-tocopherol, (C) β-tocopherol and (D) total-tocopherol (i.e. α-, γ- and β-tocopherol) starting at 2 days 

























Figure 3.6. Frequent pattern of tocopherol isoforms measurements in bovine milk (n=2): (A) α-tocopherol, 
(B) γ-tocopherol and (C) total-tocopherol (i.e. α- and γ-tocopherol) after 2 days of Tmix (mixed tocopherol 




CHAPTER 4: THE EFFECTS OF FEEDING OF MIXED TOCOPHEROL OIL 
ON BLOOD NEUTROPHIL FUNCTION AND IMMUNOMETABOLIC-
RELATED GENE EXPRESSION IN LACTATING DAIRY COWS 
ABSTRACT 
Alpha-tocopherol has been well-studied regarding improving polymorphonuclear 
leukocytes (PMN) function, especially its involvement in respiratory burst.  However, no 
studies have identified the effect of feeding a tocopherol mix, which contains additional 
isoforms, on immune cell function.  The objective of this study was to investigate how 
short-term feeding of tocopherol mix alters bovine blood PMN function and 
immunometabolic-related gene expression.  Twelve healthy, multiparous Holstein cows 
(days in milk [DIM]: 179 ± 17 d) were fed a vegetable-derived mixed tocopherol oil 
supplement (Tmix) enriched with γ- and δ-isoforms (9 % α-, 1 % β-, 24 % δ-, and 62 % 
γ-tocopherol) at ~620 g Tmix/cow·d-1 top dressed for 7 consecutive days.  Jugular blood 
(~200 mL) was collected from all cows on d 0 prior to feeding and on d 7 post-feeding of 
Tmix.  Whole blood was then used to measure, hematology, metabolites and respiratory 
burst response via chemiluminescence analysis.  Isolated PMN (3 × 106 cells/mL) were 
used to evaluate chemotaxis function and immunometabolic-regulated gene 
expression by quantitative real-time PCR.  For gene expression analysis, cells were 
incubated with lipopolysaccharide (LPS) at a final concentration either of 0.0 or 1.5 
µg/mL for 2 h.  Data were analyzed as a complete randomized design. Significance 
was declared at P ≤ 0.05.  With regard to function, Tmix improved (P = 0.04) PMN 
chemotaxis function but did not alter (P = 0.90) the respiratory burst response in whole 




inflammatory genes coding for tumor necrosis factor-α and interleukin-6.  However, 
Tmix did not alter the expression of genes associated with the immune or metabolic 
response.  In addition, Tmix did not alter plasma metabolites and hematology profile 
except for monocytes.  In conclusion, short-term feeding of Tmix did not impair PMN 
function of respiratory burst but improved PMN chemotaxis. In addition, Tmix did not 
alter the immunometabolic response of genes in PMN.  Additional evaluations of the 
effect of individual tocopherol isoforms will offer valuable information regarding their 
specific roles on bovine immune cell function and gene expression.  
INTRODUCTION 
Bovine mastitis (i.e. an inflammation of the mammary gland) is usually associated 
with the invasion of a pathogen (Gruet et al., 2001).  During mastitis, circulating PMN 
are recruited and play an essential role in controlling the duration and severity of mastitis 
(Paape et al., 2003).  Optimal PMN function during mastitis is necessary for controlling 
the inflammatory response (Lauzon et al., 2005).   However, PMN can have detrimental 
effects on the mammary tissue during the inflammatory response.  Reasons could be 
damage associated with the over production of pro-inflammatory cytokines (e.g. TNF-α; 
(Persson et al., 1993) and/or ROS (Sordillo et al., 2009).  This could result in subsequent 
disorders (i.e. ketosis and milk fever) and diseases (i.e. mastitis and metritis) that 
frequently occur in dairy cattle (Sordillo, 2016).   
Nutritional supplements of vitamin E have been studied to alleviate the negative 
consequences associated with the inflammatory responses (Barrett et al., 1997; Higuchi et 
al., 2013; Singh et al., 2013).  Potential mechanisms of vitamin E benefits during 




infiltrating PMN; 2) controlling lipid peroxidation-induced inflammation, and 3) 
modulating the membrane structure of PMN (Chew, 1995).  Alpha-tocopherol (i.e. the 
most biologically active isoform of vitamin E) has been studied for its ability to improve 
PMN chemotaxis (Luostarinen et al., 1991) and enhance the expression of plasminogen 
activator urokinase receptor gene (i.e. PLAUR) (Pinotti et al., 2003).  In addition, α-
tocopherol has been studied to improve phagocytosis of PMN in cattle (Hogan et al., 
1992) and modulate the expression of pro-inflammatory genes in PMN by controlling 
lipid peroxidation (i.e. oxidative stress) responses (Sordillo et al., 2009).  Most vitamin E 
research has been conducted during the transition period (Drackely et al., 1999; Pilotto et 
al., 2016; Qu et al., 2013), a high-risk period, when most cows experience a natural 
depletion of vitamin E (i.e. α-tocopherol) which can increase susceptibility to 
disease/disorders (Pinotti et al., 2003; Qu et al., 2013; Qu et al., 2014).  Therefore, 
sufficient vitamin E supplementation is needed to optimize animal health. 
Among the eight different isoforms of vitamin E, α-tocopherol has been studied 
the most in dairy cattle when compared to other forms, such as β-, γ- and δ-tocopherol 
(Politis et al., 2012; Spears and Weiss, 2008; Weiss and St-Pierre, 2009).  In addition, the 
common commercially available of α-tocopherol supplement is generally the more 
expensive tocopherol whereas extract mix (i.e. α-, -β-, -γ-, -δ-tocopherol) is more 
economical and can help to reduce feed costs to the producer.  However, the effect of 
Tmix on animal health has not been fully elucidated.  Therefore, the objective of this 
study was to evaluate the effect of feeding of Tmix on PMN function, as measured by 
chemotaxis and respiratory burst activity, and immunometabolic-related gene expression 




will not impair respiratory burst status, and b) Tmix will mediate the expression of pro-
inflammatory genes in circulating PMN.  
MATERIALS AND METHODS 
All procedures involving the use of live animals were approved in accordance 
with the regulations and guidelines set forth by the U.S. Department of Agriculture, 
Beltsville (# 15-009), Animal Care and Use Committee and were approved by the 
Institutional Animal Care and Use Committee at the University of Maryland, College 
Park (# 626721-1). 
Animals and Treatments 
Twelve multiparous Holstein cows in mid-lactation (DIM = 179 ± 17 d) were 
used for this study.   Cows did not display clinical signs of disease and had an average 
composite SCC of 25,000 ± 16,000 cells/mL before enrollment.  Cows were housed and 
fed in tie-stalls each with its own feed bunk, had free access to water and were milked 
twice daily at 0600 h and 1800 h.  Cows were fed a standard TMR ad libitum (Table 2.1).  
Cows were fed twice per day at 0700 h and 1400 h.  All cows were top-dressed with the 
Tmix for 7 d consecutively.  Jugular blood (~200 mL) was collected from each cow after 
the morning milking and prior to the morning feeding on d 0 and d 7 into 15-mL tubes 
containing acid-citrate dextrose (Thermo-Fisher Scientific Inc.), inverted to mix and 
placed on ice.  Blood samples were processed within 1 h after collection.  In addition, 
blood (~40 mL) was collected into EDTA tubes (Becton Dickinson Vacutainer System, 
Franklin Lakes, NJ) for whole blood chemiluminescence, whole blood hematology, 




collected after centrifugation at 1300 × g for 15 min at 4°C and stored in 1.5-mL tube at -
20°C for future analysis.   
Whole Blood Respiratory Burst by Chemiluminescence  
Reagent Preparation  
Respiratory burst was measured via chemiluminesence.  A final CaCl2 
concentration of 0.5 mM as the assay buffer was made with 500 µL of 1 M of CaCl2  
(Sigma Aldrich Inc., St. Louis, MO) and 500 mL of Hank’s Balanced Salt Solution 
(HBSS; Sigma Aldrich Inc.)  The working luminol solution (5 mM; Sigma Aldrich Inc.) 
was prepared fresh each day in a minimal assay buffer solution with 0.1-M  NaOH 
(Sigma-Aldrich Inc.).  Each tube was vortexed until luminol was in solution and 
protected from light.  For the stimulant, a working solution of phorbol 12-myristate 13-
acetate (PMA); 40 ng/µL; Sigma-Aldrich Inc.) was prepared with phosphate buffered 
saline (PBS; Sigma-Aldrich Inc.) and kept on ice.  
Chemiluminescence Assay 
Procedures followed those as previously described (Mehrzad et al., 2002) with 
minor modifications.  Briefly, for each sample test, a set of 2 tubes was filled with 500 
µL of whole blood and pre-incubated for 10 min at 37 °C in an aluminum heating block.  
Then, 20 µL of working solution of PMA (i.e. stimulant) or water (i.e. non-simulant) was 
added to achieve a final concentration of 0.8 or 0.0 µg/mL.  After incubation for 15 min 
at 37 °C, 40-µL aliquots of blood were mixed with 1 mL of minimal assay buffer 
containing luminol (250 µM).  All assay tubes were incubated for an additional 10 min at 
37 °C and transferred to the chemiluminometer (Autolumat LB 953; E. G. & G. Berthold, 
Wildbad, Germany).  Chemiluminescence generated in each tube was estimated 




= 20 reads/tube).  For each sample, mean values of the 2 tubes were used for further data 
processing.  The respiratory burst activity was expressed in relative chemiluminescence 
units.  
Hematology Analysis 
Ten mL of whole blood was used for the hematology analysis (IDEXX ProCyte 
Dx® Hematology Analyzer, Westbrook, ME) to indicate the blood profile of immune 
cells (e.g. total white cells, neutrophils, monocytes, lymphocytes) as previously described 
(Garcia et al., 2017).  
Isolation of Bovine PMN 
Blood PMN were isolated following the previous procedure described by Garcia 
et al. (2015a) with minor modifications.  Briefly, blood (~200 mL) was transferred to 15-
mL conical tubes (Thermo-Fisher Scientific Inc.) and centrifuged (Model 5810R, 
Eppendorf, Hauppauge, NY) for 20 min at 1000 × g at 4 °C.  After centrifugation, the 
plasma, buffy coat, and 1/3 of the red blood cells were discarded.  The remaining cells 
were transferred to a 50-mL tube (Thermo-Fisher Scientific Inc.) and the cell suspension 
was lysed with 18 mL of ice-cold deionized water.  The cell suspension was gently 
inverted for no longer than 45 s and isotonicity was restored by addition of 2 mL of 10 × 
PBS (pH 7.4; Sigma-Aldrich Inc.).  The solution was then centrifuged for 10 min (200 × 
g at 4 °C) and the supernatant was decanted.  The pellet was washed with 20 mL of PBS 
and centrifuged for 5 min (850 × g at 4 °C).  A total of 3 washes were performed.  After 
the final wash, the cell pellet was resuspended in 1 mL of RPMI 1640 (Sigma-Aldrich 





Cell Viability and Differential Analysis 
Cell viability was determined using the trypan blue (0.1 %, Bio-Rad Laboratories 
Inc.) exclusion method (Freshney, 1987).  The average viability was 96 % ± 1.34%.  
Ddifferential cell counts of isolated cells were determined microscopically on cytospin 
preparations using a commercially available hematology staining kit (Hema-FastTM 3-
Step Hematology Staining Kit; Thermo-Fisher, Scientific Inc.).  The average cell 
differential was 91 % ± 1.10 %). 
Treatments and Incubation 
Cell suspensions were diluted to desired concentrations of 3 × 106 cells/mL 
(chemotaxis; final volume 2.0 mL), 4 × 106 cells/mL (gene expression; final volume 2.0 
mL) using RPMI 1640 without glutamine (Sigma-Aldrich Inc.) containing 5 % heat-
inactivated fetal bovine serum (FBS; Sigma-Aldrich Inc.).   For gene expression analysis, 
200 µL of PBS containing 1.5 µg/mL LPS (LPS treatment; Escherichia coli 055:B5; 
Sigma-Aldrich Inc.) or without LPS (control treatment) were mixed with 800 µL of 
RPMI containing 4 × 106 cells/mL isolated PMN cell suspension in 24-well cell 
incubation plates.  The cell culture plates were incubated for 120 min at 37 °C, 95 % 
relative humidity and 5 % CO2.  For gene expression, following incubation, 1.0 mL of 
cell suspension was transferred to 2.0-mL RNase-free tubes (Thermo-Fisher Scientific 
Inc.) and centrifuged (1000 × g at 4 °C for 2 min).  One mL of Trizol (Thermo-Fisher 
Scientific Inc.) was added to the cell pellet, and vigorously pipetted up and down to lyse 
the cells completely for the qPCR analysis described below.  For chemotaxis, 
chemoattractants human IL-8 (Sigma-Aldrich Inc.; 100 ng/mL in Hank’s Balanced Salt 




ng/mL in HBSS) were added to the bottom of a 24-well plate in triplicate.  Filters were 
added (Pore Size 5.0 µm; 6.5 mm diameter; 0.33 cm2 growth area; Thermo-Fisher 
Scientific Inc.) to the top of each well.  The cell suspension (100 µL) adjusted to 3 × 106 
PMN/mL with RPMI-1640 containing 5% FBS was added to the top of the filter.  Plates 
were incubated for 24 h at 37 °C, 5.0 % CO2, and 95 % relative humidity.  Following 
incubation, the filter was washed 2 times with 200 µL of HBSS and the filter was 
discarded.  The total number of PMN migrating was counted using a TC-20 automated 
cell counter (Bio-Rad Laboratories Inc.).   
RNA Isolation, cDNA Synthesis, and qPCR  
Total RNA (n=6/treatment; 4 treatments total) was extracted using the Trizol 
(Thermo-Fisher Scientific Inc.) and EGA-E.Z.N.A. total RNA kit (Omega Bio-tek, Inc, 
Norcross, GA) according the manufacturer’s instructions.  Genomic DNA was removed 
with DNAase I enzyme (Bio-Rad Laboratories Inc.).  The RNA concentration was 
measured with the NanoVue Plus (GE Healthcare, Piscataway, NJ).  The purity of 
extracted RNA was calculated by absorbance ratio of 260/280 measured using the 
NanoVue Plus (GE Healthcare) with an average of 1.74 ± 0.39.  The integrity of RNA 
was measured by the RQI with an average of 8.59 ± 1.20, using an Experion Bioanalyzer 
(Bio-Rad Laboratories Inc.).   Complementary DNA (cDNA) was synthesized with 100 
ng of RNA per reaction (20 µL) using the iScript cDNA Synthesis Kit (Bio-Rad 
Laboratories Inc.).  Reactions contained 4 μL of 5X reaction mix (blend of dTand random 
hexamer primers) optimized for production of targets <1-kb in length, 1 μL of reverse 
transcriptase (RNase H+), and variable amounts of RNA templates and nuclease-free 




Inc.) with a temperature program of 25 °C for 5 min, 42 °C for 30 min, and 85 °C for 5 
min.   
Primer Selection and Evaluation 
Primer selection and efficiency curves were made following procedures described 
by (Garcia et al., 2016) and the GenBank accession number, gene symbol, hybridization 
position, sequence, amplicon size, and references for primers used can be found in 
Supplemental Table S4.1.  Briefly, primers were selected from previous publications, 
except that for NCF1 and NCF2 which were designed using Primer Express 3.0.1 with an 
intended minimum amplicon size of 80 bp (amplicons of 100-120 bp were of priority, if 
possible) and limited 3’ G + C percentage. Candidate primers were screened to verify 
proper sequence with the most updated FASTA sequence for corresponding accession 
number for Bos taurus with prefix NM_ (messenger RNA), preferentially. Lyophilized 
primers (~25 nmole DNA oligo, with a standard desalting purification method) were 
obtained from Integrated DNA Technologies (Coralville, IA).  Primers were reconstituted 
with molecular grade water (G-Biosciences, St. Louis, MO) to a concentration of 100 
µM, then diluted to a working primer concentration of 10 µM.  The amplification 
efficiency of primers was verified by a 6-point serial dilution (1:4).  Efficiency values 
ranged from 0.70 to 1.18 with an average value of 0.99 ± 0.09 and an average R2 of 0.99 
± 0.001 (Supplemental Table S4.3).  
qPCR Analysis 
Quantitative PCR reaction was performed using SYBR green dye (PerfeCta 
SYBR Green fast mix) from Quanta Biosciences Inc. (Gaithersburg, MD).  Gene symbol, 




analyzed in circulating bovine PMN are described in Supplemental Table S4.2.  Briefly, 4 
μL of cDNA template (500 pg of RNA per reaction) was combined with 5 μL of SYBR 
Green fast mix , 0.5 μL each of forward and reverse primers (500 nM of each primer per 
reaction), and 3.4 μL of molecular grade DNase/RNase free water in a skirted 96-well 
plate (VWR International, Philadelphia, PA).  All samples were run in triplicate and were 
performed on a single plate per a given gene.  The PCR reaction was performed in a 
CFX96 optical reaction module (Bio-Rad Laboratories Inc.) using the following cycling 
protocol: initial denaturation at 95 °C for 30 s, 40 PCR cycles of 95 °C for 5 s and 60 °C 
for 30 s data collection, annealing and extension,  and a final step at 95 °C for 10 s before 
the melting curve.   The melting curve step was included to verify the absence of 
formation of primer dimers and formation of single PCR products using an incremental 
temperature of 0.5 °C from 65 °C to 95 °C for 5 s.  A signal melting curve was expected 
to indicate the purity of DNA products.  The qPCR results, given as Cq values for each 
transcript, were analyzed using the 2-ΔΔCq method (Livak and Schmittgen, 2001).  Briefly, 
the Cq of each target gene was calculated and normalized by the geometric mean of the 2 
selected reference genes (RPS9, OSBPL2) (Garcia et al., 2016) to generate ΔCq values.  
The ΔCq values without transformation were used for statistical analysis.  The efficiency 
of dilution curves and median Cq values for all tested samples can be found in 
Supplemental Table S4.3. 
Analysis of Metabolites in Plasma 
Non-sterified fatty acid (NEFA), Cholesterol, Glucose, and Insulin Assays 
All plasma metabolites were run on a single 96-well plate following the 




kit (NEFA-HR kit; Wako Diagnostics Inc., Richmond, VA).  The intra-assay CV was 4.6 
%.  The plasma cholesterol assay was analyzed using the Liquicolor method from a 
commercially available kit (Stanbio Laboratories, Boerne, TX).  The intra-assay CV was 
4.6 % and inter-assay CV was 6.4 %.  Plasma glucose was analyzed by a glucose oxidase 
methodology using a commercially available kit (Stanbio Laboratories).  The intra-assay 
CV was 2.4 %.  Plasma insulin was analyzed using an ELISA kit (Thermo-Fisher 
Scientific Inc.). The intra-assay CV was 1.8 %.  
Statistical Analysis 
The PROC MIXED procedure of SAS 9.4 (2017) was used for the statistical 
analysis.  The data were analyzed as a complete randomized design.  For analysis of 
hematology profile, metabolites in plasma, whole blood respiratory burst, and PMN 
chemotaxis, the class variable included cow and Tmix.  Cow was used as a random term.  
The model included the fixed effect of Tmix supplementation (i.e. d 7 or d 0).  For 
chemotaxis, to achieve the normal distribution, cell numbers were natural log-
transformed for analysis and then back-transformed for presentation in figures and tables.  
For respiratory burst via chemiluminescence, the number of PMN in whole blood (as 
assessed via hemocytology) was added in the model as a covariate factor.  Separation of 
LSM and individual comparisons for significant effects were performed using the PDIFF 
statement in SAS.  The model was as follows: 
Yi = μ + Ti + εi 
where Yi is the dependent variable; μ is overall mean; Ti is the fixed effect of Tmix 




For gene expression analysis, and the data were analyzed using a 2 × 2 factorial 
arrangement with factors including 2 levels of Tmix supplementation (i.e. d 7 or d 0) and 
2 doses of LPS level (i.e. 0 or 1 μg/mL).  The class variable included cow, Tmix 
supplementation, LPS.  Cow was used as a random term.  The model included fixed 
effect of Tmix supplementation (0 and 7 d) and dose of LPS (LPS and control).  
Separation of LSM and individual comparisons for significant effects were performed 
using the PDIFF statement in SAS.  The model was as follows:  
Yij = μ + Ti + Lj + TLij + εij 
where Yij is the dependent variable; μ is overall mean; Ti is the fixed effect of Tmix 
supplementation at level i; Lj is the fixed effect of LPS dose at level j; TLij is the 
interaction of Tmix × LPS challenge, and εij is the residual error.  For all models, the 
degrees of freedom were estimated with the Kenward-Roger specification in the model 
statement.  The data were presented as LSM and largest SEM.  Statistical differences 
were declared as significant and highly significant at P ≤ 0.05 and P < 0.01, respectively.  
Trends towards significance are discussed at 0.05 < P < 0.10.  Fold-change values were 
calculated according to (Livak and Schmittgen, 2001).  Briefly, LSM (ΔCq) of a factor of 
interest (LPS) was subtracted from the LSM (ΔCq) of other referential factor (No LPS) to 
generate the ΔΔCq value, which was linearized to a fold-change value with the formula 2-
ΔΔCq.  
RESULTS 
Plasma Metabolites  
Concentrations of plasma glucose were not altered (P = 0.79) for cows before 




of plasma insulin were not changed (P= 0.21) for cows on d 0 before (0.23 ng/mL) and d 
7 after (0.31 ng/mL) Tmix feeding.  In addition, a trend (P = 0.09) was observed for 
concentrations of NEFA where plasma NEFA  concentrations  decreased from d 0 before 
(0.42 mEq/L) and d 7 after (0.27 mEq/L) Tmix feeding.  The concentrations of plasma 
cholesterol did not significantly change (P = 0.53) for cows on d 0 before (392.03 mg/dL) 
or d 7 after (315.63 mg/dL) Tmix feeding. 
Hematology Profiles 
Whole blood hematology profiles of immune cells before (i.e. d 0) and after (i.e. d 
7) Tmix feeding are shown in Table 4.1.  Concentrations of white blood cells were not 
changed (P =0.15) after 7 d of Tmix feeding relative to baseline measurements at d 0.  
Among those white blood cells, concentrations of PMN, lymphocytes, basophils, and 
eosinophils were not changed (P ≥ 0.17) on d 7 after Tmix feeding relative to baseline.  
However, concentrations of monocytes were increased (P = 0.04) relative to baseline 
after 7 d of Tmix feeding (Table 4.1). 
Whole Blood Respiratory Burst by Chemiluminescence   
Feeding Tmix did not affect (P = 0.90) the respiratory burst of whole blood by d 7 
of Tmix supplementation as determined by relative chemiluminescence response (Figure 
4.1). 
Chemotaxis of Bovine PMN 
Feeding cows Tmix increased (P = 0.03; Figure 4.2A) the number of PMN 
migrating in response to IL-8 chemoattractant and tended to increase (P = 0.10; Figure 
4.2B) the number of PMN migrating in response to C5a chemoattractant after 7 d of 




PMN Gene Expression 
The effects of Tmix supplementation and LPS challenge on PMN gene expression 
are shown in Table 4.2.  There was no significant interaction (P > 0.05) between LPS 
challenge and Tmix supplementation.  Tmix did not affect (P > 0.05) the expression of 
genes coding for the inflammatory response of bovine PMN (i.e. IL6, IL8, IL10, NFKB1, 
PTGS-2), except for MYD88 (1.58 FC, P < 0.05) and TNFA (1.69 FC, P < 0.05).  Tmix 
supplementation did not affect the expression of genes coding for the receptors on the 
surface of bovine PMN involved in inflammatory signaling pathways (i.e. TLR2 and 
TLR4) nor genes coding for adhesion/receptors (i.e. SELL and ITGB2).  In addition, Tmix 
did not affect the expression of PLAUR coding for receptors specifically reacting with 
tocopherol to improve PMN chemotaxis function.  Tmix did not affect the expression of 
CASP and mTOR coding for proteins involved in cell signaling pathways.  Tmix did not 
affect the expression of (PPARα, RXRα, or RXRβ), but increased expression of RARα 
(1.28FC, P = 0.03). 
There was no significant interaction of LPS and Tmix for any of the genes 
analyzed.  The LPS challenge increased the expression of inflammatory genes: TNFA 
(3.92 FC, P < 0.01), NFKB1 (1.06 FC, P < 0.01), IL6 (2.71 FC, P < 0.01), IL10 (1.97 FC, 
P < 0.01) and PTGS-2 (4.46 FC, P < 0.01), but not the expression of other genes.  LPS 
challenge intended to increase the expression of TLR2 (1.35 FC P=0.09, Table 4.2) 
coding for the cellular receptor molecule involved in cell interactions of PMN.  However, 
it did not affect the expression of other adhesion/receptors (SELL, ITGB2 and PLAUR) of 
PMN.  LPS challenge increased the expression of NOS2 (2.12 FC, P < 0.01) whereas 




LPS challenge did not affect the expression of CASP3 or mTOR coding for proteins 
involved in cell signaling pathways.  LPS challenge did not affect the expression of 
PPARα, RXRα, RXRβ or RARα coding for transcription factors involved in tocopherol-
related metabolism in bovine PMN.   
DISCUSSION 
This study demonstrates that supplementing Tmix may not alter health of the cow 
in mid-lactation because 1) metabolic profiles (i.e. plasma glucose, insulin and 
cholesterol) were not altered by Tmix supplementation; 2) Tmix did not alter the 
hematology profile of whole blood (i.e. red and white blood cell concentrations); 3) Tmix 
did not impair the whole blood oxidative burst responses;4) Tmix increased the PMN 
chemotaxis ability; and 5) Tmix showed minimal effects on the immunometabolic gene 
expression of isolated PMN with or without LPS stimulation. 
 Tmix did not Alter Blood Metabolic or Hematology Profiles  
Metabolic profiles such as glucose and insulin showed similar results to previous 
studies (Garcia et al., 2016; Qu et al., 2013), and tocopherol mix oil supplementation 
decreased the NEFA concentration to a normal level of ~0.25 mEq/L (Bionaz et al., 
2007).  In the current study, mean plasma cholesterol was greater (~300 mg/dL) than 
previous reports in the literature (~200 mg/dL) (Kessler et al., 2014; Qu et al., 2013).  
Diet and BW could contribute to this difference (Faye et al., 2015).  Tmix feeding did not 
change the level of plasma cholesterol (P=0.53).  With regard to the hematology profile, 
Tmix did increase the monocytes population.  This may indicate that Tmix is beneficial 




critical as macrophages (converted from monocytes) serve as the first immune cells to 
encounter pathogens during disease (Yang et al., 2014).   
Tmix Improved PMN Chemotaxis Function but did not Limit Oxidative Burst 
Responses 
Tocopherol mix oil supplementation for 7 d increased PMN chemotaxis function.  
Chemotaxis by PMN is needed during inflammation and serves as the primary defense 
mechanism of the innate immune system (Paape et al., 2003).  The chemoattractants IL-8 
and C5a, are chemokines that activate PMN during the chemotaxis process (Kobayashi, 
2008).   A previous study in bovine milk PMN reported that supplementing α-tocopherol 
increases PMN chemotaxis function and the mechanism could be associated with the 
increased expression of PLAUR (plasminogen activator, urokinase receptor) (Politis et 
al., 2003).  Another possible mechanism could be the interaction between tocopherol and 
cell membrane futility during PMN movement due to the tocopherol accumulated mainly 
in the cell membrane structure, which has not been clarified (Paape et al., 2003).  In this 
study, in order to understand the possible mechanism of Tmix increasing chemotaxis 
function, the expression of PLAUR was tested (see below for discussion).  
Tocopherol mix oil did not alter the whole blood oxidative burst response, as 
measured by the chemiluminescence assay.  Reasons could be associated with  using 
whole blood instead of isolated PMN and/or the effect of tocopherol on respiratory burst 
may be primarily associated with the α-isoform of vitamin E (Cachia et al., 1998).  In 
vitro studies in humans have shown that both α-tocopherol and γ-tocopherol serve as 
antioxidants and inhibit the superoxide molecules in PMA-stimulated PMN via regulating 




However, the present data did not show that Tmix inhibited oxidative burst responses in 
whole blood.  Phorbol 12-myristate 13-acetate was chosen for incubation with blood 
instead of LPS to mimic the production of superoxide molecules by PMN during 
phagocytosis (Tian et al., 2005) because unlike LPS, PMA does not require a cell surface 
receptor (e.g. TLR-4) or LPS binding protein to stimulate PMN oxidative burst (Akira 
and Hemmi, 2003).  Further studies need to be conducted to investigate the effects of 
Tmix on PMN respiratory burst and the effect of individual tocopherol isoforms on both 
whole blood and PMN respiratory burst responses.  Overall, feeding Tmix did not impair 
the whole blood oxidative burst response but improved the PMN chemotaxis function of 
cows in mid-lactation. 
LPS Induced a Pro-Inflammatory Response Regarding the Immunometabolic Gene 
Expression of PMN 
In vitro LPS challenge was used to mimic the pro-inflammatory response of PMN 
using a dose similar to previous study reported for cows in mid-lactation (Sohn et al., 
2007).  Lipopolysaccharide challenge increased the expression of genes coding for pro-
inflammatory mediators (e.g. cytokines).  Lipopolysaccharide challenge increased 
expression of NFKB, coding for the inflammatory transcription factor NF-κB, coupled 
with an increased expression of pro-inflammatory genes (e.g. IL6 and TNFA) coding for 
pro-inflammatory cytokines.  Lipopolysaccharide challenge increased the mRNA 
expression of the anti-inflammatory cytokine IL10.   Lipopolysccharide challenge tended 
to increase the expression of TLR2 coding for TLR-2 observed in LPS-stimulated PMN 
(Yang et al., 1998).  Results of the current study were consistent with a previous study 




challenge increased the expression of NOS2, coding for the nitric oxide synthase induced 
by LPS stimulation in PMN (Okamoto et al., 2004).  Even though the concentration of 
TNF-α in media was not tested in the current study, previous studies using a similar LPS 
dose showed increased pro-inflammatory cytokine concentrations (i.e. TNF-α and IL-8) 
in cell culture media  
Tmix Showed Minimal Effects on the Immunometabolic Gene Expression of PMN 
Feeding Tmix increased the expression of TNFA and increased the expression of 
NFKB1, coding for TNF-α and NF-κB respectively.  In addition, Tmix increased the 
expression of MYD88, coding for an adapter protein important during LPS challenge. The 
increased expression of MYD88 might be more associated with the increased expression 
of NFKB1 than TLR in the current study.  Contrary to the present data, a previous study 
showed that giving α-tocopherol decreased the expression of NFKB1 in rat immune cell 
lines during inflammatory responses via either LPS or TNF-α incubation (Li-Weber et 
al., 2002).  The possible mechanism could be the antioxidant ability of α-tocopherol, 
which reduces the production of superoxide anions that can induce the proinflammatory 
responses via NF-κB signaling pathways (Conner and Grisham, 1996).  Besides α-
tocopherol, γ-displays anti-inflammatory capabilities by serving as an antioxidant to 
scavenge .NO2
.thereby reducing the expression of cyclooxygenase-2 (COX2) and/or 
inducing the transcription factor PPAR-γ via decreased production of prostaglandins by 
COX2 reduction (Campbell et al., 2003).  In the current study, Tmix (highly enriched 
with γ-tocopherol) did not alter the expression of COX2, an enzyme responsible for 
formation of prostanoids during inflammation.  It is possible that tocopherol metabolized 




tocopherol (Egger et al., 2003; Grammas et al., 2004).  Ultimately, compared to previous 
studies, the present results showed different effects of tocopherol on the expression of 
pro-inflammatory genes (i.e. TNFA, NFKB1 and MYD88).  Reasons could be associated 
with the fact that Tmix being comprised all four isoforms wherein β- or δ-tocopherol may 
have interacted with α- or γ-tocopherol in pro-inflammatory pathways or the tocopherol 
treatment was performed in vivo through feeding, whereas previous studies were 
completed entirely in vitro (Maziere et al., 1996; Erl et al., 1997; La et al., 2002).  Further 
studies need to be conducted to compare the effects of Tmix to individual α- or γ-
tocopherol on the PMN expression of pro-inflammatory genes.  
Tocopherol mix oil did not alter the expression of PLAUR coding for plasminogen 
activator urokinase receptor, a potential mechanism involved in PMN chemotaxis.  A 
previous study demonstrated supplementation of  α-tocopherol increased the expression 
of PLAUR and chemotaxis function (Pinotti et al., 2003) in milk PMN.  In addition, Tmix 
did not alter the expression of ITGB2 and SELL coding for CD18 and L-selectin, 
respectively, which are adhesion molecules involved in PMN movement along blood 
vessel walls during chemotaxis (Paape et al., 2003).  The improved chemotaxis function 
results in the current study might not be associated with PMN surface receptors/adhesion 
mechanisms, but with affecting PMN membrane futility during its movement, 
considering the assumption of tocopherol being mainly located in plasma membrane due 
to its chemical propensities (Li and May, 2003).  Further studies need to be conducted to 
identify the mechanisms associated with improving PMN chemotaxis via tocopherol 
supplementation.  Tocopherol mix oil did not alter the expression of TLR4 and TLR2 




LPS challenge to induce pro-inflammatory responses in PMN (Aderem and Ulevitch, 
2000).  It was expected that Tmix would depress the expression of TLR4 or TLR2 to 
inhibit the pro-inflammatory responses via LPS challenge.  The results did not show 
changes in the expression of these two genes which might indicate that tocopherol did not 
interact with PMN surface receptors even though tocopherol is located mainly in the cell 
membrane during LPS challenge. This needs to be confirmed via an in vitro incubation 
experiment. 
Tocopherol mix oil increased the expression of SOD2 coding for superoxide 
dismutase 2 as an enzyme to scavenge superoxide molecules when PMN are activated via 
LPS challenge, similar to previous study that showed α- or γ-tocopherol increasing the 
expression of SOD2 in rats (Saldeen et al., 1999).  However, the present data showed that 
Tmix increased the expression of NCF1 coding for the subunit of NADPH oxidase to 
produce superoxide molecules in activated PMN.  This might partly explain the above 
chemiluminescence data wherein Tmix did not alter the oxidative burst responses of 
whole blood possibly due to interactions with the other tocopherol isoforms (i.e. β- and δ-
tocopherol).  In addition, Tmix showed no effect on the expression of CASP3 coding 
mediators involved in cell apoptosis pathways and on the expression of mTOR coding 
central regulator involved in mammalian metabolism.  
Furthermore, Tmix did not alter the expression of PPARα coding for nuclear 
peroxisome proliferator-activated receptors and the expression of RXRα and RXRβ both 
coding for the retinoid X receptor, which are involved in tocopherol metabolism.  
According to previous studies, tocopherol served as a ligand to bind with PPARα paired 




Traber, 2004).  Tmix increased the expression of RARα, coding for the retinoic acid 
receptor involved in regulation of retinoic acid (Chen, 2013).  In current study, the 
increased RARα expression might be attributed to the negative interaction of retinoic acid 
and tocopherol (Schelling et al., 1995).  Overall, the current data did not demonstrate any 
major changes in PMN gene expression associated with tocopherol metabolic functions 
despite their roles in phagocytosis, chemotaxis etc. In other cell types, such as liver, 
tocopherol supplementation altered expression of genes associated with metabolic 
functions (Traber, 2013).  
CONCLUSIONS 
In summary, the present study measured for the first time the effect of Tmix 
supplementation on PMN functions and gene expression changes in dairy cows in mid-
lactation.  The current results demonstrate that Tmix supplementation could be used like 
the pure α-tocopherol supplement (i.e. common vitamin E in cows) in the dairy industry 
because Tmix did not show any adverse effects on the health of cows in mid-lactation.  
The blood, milk and tissue results showed that tocopherol concentrations were able to 
accumulate at a desirable level to meet the cow’s dietary requirement via short-term 
feeding of Tmix.  In addition, this work was the first to investigate the effect of Tmix on 
a number of immunometabolic genes in bovine PMN following a LPS challenge.  Tmix 
showed limited effects on PMN responses to LPS challenge.  Even though Tmix 
increased the expression of pro-inflammatory genes, it does not indicate that high 
expression of those genes is harmful to PMN.  The increased expression of pro-
inflammatory genes (i.e. TNFA, IL6) might be necessary during the initiation of innate 




by which Tmix increased the PMN chemotaxis functions and aided the whole blood 
oxidative burst response remains unclear.  Future studies are warranted to compare and 
understand the mechanism of Tmix and individual tocopherol isoform effects on PMN 
function and oxidative burst response. 
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Tocopherol mix and Bovine neutrophils Chapter Tables and Figures: 
TABLES: 
Table 4.1. Whole blood hematology profiles of immune cells before (i.e. 0 d) and after (i.e. 7 d) feeding a 
tocopherol supplement1 to 12 Holstein cows during mid-lactation. 
Cell population  
Tmix feeding 
SEM P-value 
Day 0 Day 7 
Basophils, 103/µL 0.01 0.01 0.01 0.30 
Eosinophils, 103/µL 0.35 0.36 0.08 0.80 
Lymphocytes, 103/µL 4.00 4.10 0.23 0.18 
Monocytes, 103/µL 0.80 0.90 0.05 0.04 
Neutrophils, 103/µL 2.80 3.20 0.20 0.17 
White blood cells, 103/µL 8.00 8.70 0.40 0.15 
1Mixed tocopherol oil supplement (Tmix): 300g of (9 % α-, 1 % β-, 24 % δ-, and 62 % γ-
tocopherol) pure tocopherol mixed with 22.68 kg of calf grower (Farmers Cooperative 





























Table 4.2. Effect of feeding a tocopherol supplement1 and LPS challenge2 on the expression of genes from 
bovine neutrophils from Holstein cows during mid-lactation (n=6/treatment). Data were analyzed using the 
2-ΔΔCt method and presented as fold-change (FC; 7/ 0 d). 
 D 7 vs. D 0                         +LPS vs. -LPS 
FC P-value  FC P-value 
Pro/anti-inflammatory 
genes 
     
COX2(PTGS-2) 1.35 0.32  4.46 <0.01 
IL6 1.08 0.71  2.71 <0.01 
IL10 1.21 0.36  1.97 <0.01 
MYD88 1.58 0.02  1.05 0.89 
NFKB1 1.38 0.05  1.06 <0.01 
TNFA 1.69 0.04  3.92 <0.01 
Adhesion/receptor genes      
ITGB2 1.01 0.65  1.00 0.98 
PLAUR 0.99 0.96  1.35 0.15 
SELL 1.20 0.28  0.90 0.57 
TLR2 1.97 0.30  1.35 0.09 
TLR4   1.03 0.88  1.29 0.22 
Superoxide enzyme genes      
NCF1 1.47 <0.01  0.97 0.82 
NCF2 1.16 0.50  0.84 0.45 
NOS2 0.98 0.93  2.12 <0.01 
SOD2 1.47 0.03  1.29 0.15 
Cell apoptosis genes      
CASP3 1.12 0.46  1.06 0.71 
Cell signaling genes      
mTOR 0.96 0.90  0.75 0.43 
Transcription factor genes      
PPARα 1.03 0.86  0.96 0.83 
RARα 1.28 0.03  0.97 0.77 
RXRα 1.14 0.50  0.96 0.82 
RXRβ 1.04 0.70  1.05 0.62 
1Mixed tocopherol oil supplement (Tmix): 300g of (9 % α-, 1 % β-, 24 % δ-, and 62 % γ-
tocopherol) pure tocopherol mixed with 22.68 kg of calf grower (Farmers Cooperative 
Association Inc.), then fed to all cows at ~620 g/d for 7 consecutive days. 
2On  0 d and  7 d,bovine neutrophils were isolated from dairy cows fed mixed tocopherol oil 
supplement (Tmix) and incubated with or without lipopolysaccharide (+/- LPS) (1.5 µg/mL) for 2 










                                                                          Tmix feeding 
 
Figure 4.1. The effect of mixed tocopherol oil supplement (Tmix) on whole blood respiratory burst 
response as measured by chemiluminescence on 0 d before and 7 d after feeding of Tmix to 12 Holstein 














 Figure 4.2. The effect of mixed tocopherol oil supplement (Tmix) on bovine neutrophil chemotactic 
response to (A) bovine interleukin-8 and (B) bovine complement component 5a on 0 d before and 7 d of 
feeding of Tmix to 12 Holstein cows during mid-lactation. 





CHAPTER 5: SUMMARY AND CONCLUSIONS 
The three objectives of this study were: 1) to investigate the accumulation and 
distribution level of all four tocopherol isoforms in bovine tissue and mitochondria; 2) to 
investigate the pattern change of all four tocopherol isoforms (α-, β-, γ-, and δ-tocopherol 
in bovine blood and milk; and 3) to investigate the effect of all four tocopherol isoforms 
on bovine PMN function and immune-metabolic-related gene expression via Tmix 
supplementation of dairy cows. 
In Chapter 2, the objective was to investigate the accumulation and distribution 
level of all four tocopherol isoforms in bovine tissue and mitochondria via Tmix 
supplementation.  The results indicated that Tmix supplementation increased γ-
tocopherol concentrations, but did not increase the α-tocopherol concentration in three 
different types of tissues (i.e. liver, mammary gland and muscle) and liver mitochondria.  
Within those three different types of tissues, liver showed the highest ability to store 
tocopherol isoforms (i.e. α- and γ-tocopherol) compared to the other tissues.  Also, 
amounts of α- and γ-tocopherol were detected in liver mitochondria, but limited amounts 
were detected in mammary gland mitochondria.  It is concluded that the majority of α- 
and γ-tocopherol was absorbed into the liver as compared to the mammary gland in both 
gross tissue and mitochondria.  The high concentration of tocopherol isoform 
accumulation in liver supports the proposed Tmix supplementation strategies of targeting 
liver to mitigate disrupted metabolic issues using vitamin E supplements during the 
transition period in dairy cows.  
In Chapter 3, the objective was to investigate the pattern change of all four 




supplementation.  It was demonstrated that supplementation of Tmix could increase γ-
tocopherol concentration in milk and blood and via frequent measurements.  Even though 
daily data showed that the α isoform concentrations were highest, Tmix supplementation 
increased γ concentrations in milk and blood as compared to α-tocopherol (Figures 3.1 
and 3.2).  Non-detectable of β- and δ-tocopherol were observed in milk and blood via 
Tmix supplementation.  Tmix provided adequate γ-tocopherol concentration (i.e. ~3.2 
µg/mL) in blood and exceeded the required value (~3 µg/mL) in dairy cows (Weiss, 
1998).  In addition, daily measurement results showed that Tmix could provide the high 
and stable concentrations of both necessary α- and γ-tocopherol isoforms in milk and 
blood via supplementation for 5 consecutive days.  This result could provide a new aspect 
of vitamin E supplement strategies to meet necessary vitamin E requirements (i.e. α- and 
γ-tocopherol) in dairy cows, especially when stored vitamin E is depleted during the 
transition period in dairy cows (Qu et al., 2014).  The results support the hypothesis that 
Tmix could enrich α- and γ-tocopherol isoform concentrations in blood and milk.   
In Chapter 4, the objective was to investigate the effect of all four tocopherol 
isoforms on bovine PMN function and immune-metabolic-related gene expression via 
Tmix supplementation.  The results indicated that Tmix increased PMN chemotaxis 
function and did not impair the whole blood respiratory burst response, which might be 
associated with non-α-tocopherol isoforms present in the Tmix.  The increased 
expression of pro-inflammatory genes (e.g. TNFA and IL6) might be necessary for the 
initiation of innate immune functions and further activation of adaptive immune 




Therefore, it might be concluded that Tmix supplementation will not harm PMN 
functions. 
Overall, it was demonstrated that Tmix supplementation for 5 consecutive days 
could increase γ-tocopherol without altering α-tocopherol in dairy cows.  The liver 
showed the highest capability of accumulating tocopherol isoforms compared to the 
mammary gland and muscle.  The liver could be the potential target of mitigating 
metabolic issues using Tmix (highly enriched with γ-tocopherol) in dairy cows during the 
transition period.  Besides, Tmix did not harm immune functions nor alter animal health 
in dairy cows as measured by PMN chemotaxis, respiratory burst response, hematology 
profiles and plasma metabolites.  Therefore, the potential Tmix supplementation 
strategies could be developed to focus on mitigating liver metabolic issues caused by 
biological stress (i.e. oxidative stress and nitroxidative stress) and improving animal 
















Supplemental Table S2.1. Protein concentration in isolated mitochondrial fraction from liver and 
mammary gland tissue. 
Mitochondrial source Feeding group Protein concentration (mg/mL) 
Liver Tmix1 6.08 
Liver Tmix 6.34 
Liver Tmix 6.56 
Liver Tmix 6.51 
Liver Tmix 5.38 
Liver Control2 6.20 
Liver Control 8.09 
Liver Control 8.65 
Mammary gland Tmix 2.23 
Mammary gland Tmix 1.72 
Mammary gland Tmix 1.23 
Mammary gland Tmix 2.68 
Mammary gland Tmix 3.07 
Mammary gland Control 2.77 
Mammary gland Control 1.43 
Mammary gland Control 1.55 
1Mixed tocopherol oil supplement (Tmix; n=5): 300 g of (9 % α-, 1 % β-, 24 % δ-, and 62 % γ-
tocopherol) pure tocopherol mixed with 22.68 kg of calf grower (Farmers Cooperative 
Association Inc.), then fed to all cows at ~620 g/d for 9 consecutive days. 













Supplemental Table S2.2: GenBank accession number, gene symbol, hybridization position, 
sequence, amplicon size, and references for Bos taurus primers used to analyze gene expression 
by qPCR in bovine tissues.   
Accession # Gene 
Symbol 




NM_001035042.1 CYP4F2 F.15 ACAAGCCGCTCTTGACAGAA 196 6 
  R.191 GAGGCGACGAGAGTTGTTGT   





BC149232.1 LRP10 F.2487 CCAGAGGATGAGGACGATGT 139 7 
  
R.262 CCAGAGGATGAGGACGATGT   
NM_001076409.1 NFKB1 F.172 TTCAACCGGAGATGCCACTAC 95 3 
  R.266 ACACACGTAACGGAAACGAAATC   
NM001103226.1 NR1I2 F.1332 TGAAGGCCTACATCGAGTTCAAC 68 5 
  R.1379 GGCCATGATCTTCAGGAACAA   
NM_001079768.2 NR1I3 F.312 GAAGGACATGATCCTATCGACAGA 63 1 
  R.358 CGTCGCTGGGCCTGTCT   
NM_181024.2 PPARG F.494 AATCAAAGTGGAGCCTGTATC 343 4 
  R.787 CCTGATGGCATTATGAGACA   
NM_001304343.1
11 
RXRα F.408 CGCTCCTCAGGCAAGCA 121 8 
  R.506 TGTCAATCAGGCAGTCCTTGTT   
NM_001083640.1 RXRβ F.1232 CGTGGGAGCCATCTTCGA 60 8 
  R.1273 CTCATGTCCCGCATTTTGG   
NM_174597.2 SCARB1 F.1241 GGAATCCCCATGAACTG 366 2 
  R.1588 CTTGGGAGCTGATGTCATC   
NM_177943.2 SEC14L2 F.1145 GCAGCGATCCTGGCATCTAT 109 6 
  R.1233 TCTGAGGCTTTGTCTGGAAGC   
NM_001206676.1 TTPA F.1329 GCCACCAAGCTAGTTCACCT 113 6 
  R.1422 CCTAGAGACCTGATGCAGCG   
1Cantiello, M., M. Giantin, M. Carletti, R. M. Lopparelli, F. Capolongo, F. Lasserre, E. Bollo, C. 
Nebbia, P. G. P. Martin, T. Pineau, and M. Dacasto. 2009. Effects of dexamethasone, 
administered for growth promoting purposes, upon the hepatic cytochrome P450 3A expression 
in the veal calf. Biochem. Pharmacol. 77:451-463. 
 
2Giantin, Me., R. M. Lopperalli, V. Zancanella, P. G. Martin, A. Polizz, G. Gallina, F. Gottardo, 
C. Montesissa, L. Ravarotto, T. Pineau, and M. Dacasto. 2010. Effect of illicit dexamethasone 
upon hepatic drug metabolizing enzymes and related transcription factors mRNAs and their 
potential use as biomarkers in cattle. J. Agric. Food Chem. 58: 1342-1349. 
 
3Janovick-Guretzky,  N. A., H. M. Dann, D. B. Carlson, M. R. Murphy, J. J. Loor, and J. K. 
Drackley. 2007. Housekeeping gene expression in bovine liver is affected by physiological state, 
feed intake, and dietary treatment. J. Dairy Sci. 90:2246-2252. 
 
4Liu, X., G. Liu, X. Tan, H. Zhao, H. Cheng, F. Wan, N. Wu, and E. Song. 2014. Gene 
expression profiling of SIRT1, FoxO1, and PPARγ in backfat tissues and subcutaneous adipocytes 





5Rohrer, L., P. M. Ohnsorg, M. Lehner, F. Landolt, F. Rinninger, and A. V. Eskardstein. 2009. 
High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI 
and ATP-binding cassette transporter G1. Mol. Med. 104:1142-1150. 
 
6Sadri, H., S. Dänicke, U. Meyer, J. Rehage, J. Frank, and H. Sauerwein. 2015. Tocopherols and 
tocotrienols in serum and liver of dairy cows receiving conjugated linoleic acids or a control fat 
supplement during early lactation. J. Dairy Sci. 98:7034-7043. 
 
7Saremi, B., H. Sauerwein, S. Dänicke, and M. Mielenz. 2012. Technical note: Identification of 
reference genes for gene expression studies in different bovine tissues focusing on different fat 
depots. J. Dairy Sci. 95:3131–3138. 
 
8Schmitt, E., M. A. Ballou, M. N. Correa, E. J. DePeters, J. K. Drackley, and J. J. Loor. 2011. 
Dietary lipid during the transition period to manipulate subcutaneous adipose tissue peroxisome 

































Supplemental Table S2.3: Efficiency of dilution curves and median Cq values for all tested 
samples. 
  Dilution curve1   Cq Values across all samples2 
Tissue/Gene Slope3 R2 4 Efficiency5 
 
Lower value Higher value Median Cq 
Liver 
       
CYP4F2 -3.28 0.99 1.02 
 
27.83 30.29 29.01  
HPCAL1 -3.11 0.99 1.09 
 
28.36 30.67 30.14  
LRP10 -3.15 0.98 1.08 
 
25.19 27.85 26.78 
NFKB1 -3.65 0.99 0.96 
 
27.55 30.05 29.59 
NR1I2 -3.44 0.99 0.95 
 
26.08 29.42 27.78 
NR1I3 -3.17 0.99 1.07 
 
25.32 27.46 26.45 
RXRα -3.59 0.99 0.90 
 
23.99 26.31 24.99 
RXRβ -3.22 0.99 1.04 
 
27.70 29.71 28.90 
SEC14L2 -3.57 0.99 0.90 
 
27.16 25.02 25.91 
TTPA -3.51 0.99 0.93 
 
23.12 25.90 24.58 
Mammary  
       
HPCAL1 -3.31 0.99 1.00 
 
28.75 30.33 29.70 
LRP10 -3.17 0.99 1.07 
 
25.08 27.55 26.50 
NFKB1 -3.26 0.98 1.02 
 
27.67 30.84 29.31 
PPARG -3.46 0.98 0.94 
 
28.44 30.74 30.07 
RXRα -3.18   0.99       1.06 
 
26.96 28.54 27.55 
RXRβ -3.34 0.99 0.99 
 
27.85 29.75 28.93 
SCARB1 -2.97 0.99 1.17 
 
29.64 33.77 31.34 
 
Muscle 
       
LRP10 -3.47 0.99 0.94 
 
27.55 31.06 29.61 
HPCAL1 -3.26 0.99 1.02 
 
30.89 34.42 32.87 
NFKB1 -3.62 0.99 0.89 
 
30.15 34.17 31.98 
RXRα -3.51 0.99 0.93 
 
26.68 30.74 28.23 
RXRβ -3.33 0.99 0.99 
 
     29.40 31.45 30.58 
1 Efficiency was tested with 6 serial dilutions (1:4). 
2Cq values corresponding to all analyzed samples for each corresponding gene using 4 µL of 
cDNA. template per reaction generated from 500 ρg of RNA.  
3Slope of the dilution curve. 
4Coefficient of determination of the dilution curve. 










Supplemental Table S2.4. Gene symbol, gene name, and description of the main biological 
functions and processes of targets analyzed in bovine tissues. 
Symbol Name 
   Summary description form GENECARDS 





This gene encodes a member of the cytochrome P450 superfamily of 
enzymes. The cytochrome P450 proteins are monooxygenases which 
catalyze many reactions involved in drug metabolism and synthesis of 
cholesterol, steroids and other lipids.  
HPCAL1 Hippocalcin Like 1 The protein encoded by this gene is a member of neuron-specific 
calcium-binding proteins family found in the retina and brain. It serves 
as housekeeping genes in this study. 
LRP10 LDL Receptor 
Related Protein 10 
This gene encodes a low density lipoprotein receptor family protein. It 
serves as housekeeping genes in this study. 
NFKB1 Nuclear Factor 
Kappa B Subunit 1 
This gene encodes for a DNA binding subunit of the NF-kappa-B 
(NFKB) protein complex. NFKB is a transcription regulator that is 
activated by various intra- and extra-cellular stimuli such as cytokines, 
oxidant-free radicals, ultraviolet irradiation, and bacterial or viral 
products. 
NR1I2(PXR) Nuclear Receptor 
Subfamily 1 Group 
Member 2 
This gene product belongs to the nuclear receptor superfamily, 
members of which are transcription factors characterized by a ligand-
binding domain and a DNA-binding domain. The encoded protein is a 
transcriptional regulator of the cytochrome P450 gene CYP3A4, 
binding to the response element of the CYP3A4 promoter as a 
heterodimer with the 9-cis retinoic acid receptor (RXR).  
NR1I3(CAR) Nuclear Receptor 
Subfamily 1 Group 
Member 3 
This gene encodes a member of the nuclear receptor superfamily, and 
is a key regulator of xenobiotic and endobiotic metabolism. The 
protein binds to DNA as a monomer or a heterodimer with the retinoid 
X receptor and regulates the transcription of target genes involved in 
drug metabolism and bilirubin clearance, such as cytochrome P450 





This gene encodes a member of the peroxisome proliferator-activated 
receptor (PPAR) subfamily of nuclear receptors. PPARs form 
heterodimers with retinoid X receptors (RXRs) and these heterodimers 
regulate transcription of various metabolic function genes. 
RXRα Retinoid X 
Receptor 
Alpha 
Retinoid X receptors (RXRs) and retinoic acid receptors (RARs) are 
nuclear receptors that mediate the biological effects of retinoids by 
their involvement in retinoic acid-mediated gene activation.  
RXRβ Retinoid X 
Receptor Beta 
This gene encodes a member of the RXR family of nuclear receptors 
which are involved in mediating the effects of retinoids. 
SCARB1 Scavenger 
Receptor Class B 
Member1 
The protein encoded by this gene is a plasma membrane receptor for 
high density lipoprotein cholesterol (HDL). The encoded protein 
mediates cholesterol transfer to and from HDL. 
SEC14L2 SEC14 Like Lipid 
Binding 2 
This gene encodes a cytosolic protein which belongs to a family of 
lipid-binding proteins including alpha-tocopherol transfer protein and 
cellular retinol-binding protein.  
TTPA Alpha Tocopherol 
Transfer Protein 
This gene encodes a soluble protein that binds alpha-trocopherol, a 
form of vitamin E, with high selectivity and affinity. This protein plays 




transporting vitamin E between membrane vesicles and facilitating the 






































Supplemental Table S4.1: GenBank accession number, gene symbol, hybridization position, 
sequence, amplicon size, and references for Bos taurus primers used to analyze gene expression 
by qPCR in bovine PMN. 
Accession # Gene 
Symbol 




      
NM_001077840.1 CASP3 F.454 AAGCCATGGTGAAGAAGGAA 112 4 





  R.252 GGCAAAGAATGCAAACATCA   
NM_001034034.2 GAPDH F.908 TTGTCTCCTGCGACTTCAACA 103 5 
  R.1010 TCGTACCAGGAAATGAGCTTGAC   
NM_173923.2 IL6 F.190 CCAGAGAAAACCGAAGCTCTCAT 100 9 
  R.289 CCTTGCTGCTTTCACACTCATC   
NM_174088.1 IL10 F.429 GAGAGTCTTCAGTGAGCTCCAAGAG 101 7 
  R.529 GCATCTTCGTTGTCATGTAGGTTT   
NM_175781.1 ITGB2 F.1230 GACACCCTGAAAGTCACCTACGA 65 12 
  R.1317 GAAGGTGATCGGGACGTTGAT  
NM_001014382.2 MYD88 F.366 GGAGGACTGCCAAAAGTATATTCTG 104 7 
  R.447 GCCATGTCATTTATCCGAGTTATG  
XM_002694043.3 mTOR F.3452 CCCCGATCGTGAAGTTATTTG 141 10 
  R.3592 GTGTGCGTACAATCGGATGAA   
NM_174119.4 NCF1 F.369 TCCTCAACTTCTTCAAGGTGCG 108    This paper 
  R.455 CAGCGTTGTTCTTGCCATCTTT  
NM_174120.2 NCF2 F.1302 GCCCCTTTCAGAATTCAGCAT 107   This paper 
  R.1341 GCGTCAGGCAGTAGTTTTTCACT  
NM_001076409.1 NFKB1 F.172 TTCAACCGGAGATGCCACTAC 95 9 
  R.266 ACACACGTAACGGAAACGAAATC   
NM_001076799.1 NOS2 F.124
7 







BT021611.1 OSBPL2 F.198 TGCCGTCACAGGCTTTGAC 100 8 
  R.297 CCATTACTTGCTGGTGTCCACAT   
NM_174423.3 PLAUR F.174 GTCCTGAGTGTGTGGGAAGG 140 6 
  R.332 CAGTAGCATCTCGACCAGGG  
NM_001034036.1 PPARα F.727 CATAACGCGATTCGTTTTGGA 62 7 
  R.811 CGCGGT TTCGGAATCTTCT  
NM_001014942.3 RARα F.794 CAAGACAAATCCTCCGGCTA 220 3 
  R.991 TGTTCCGGTCATTTCTCACA  
NM_001101152.2 RPS9 F.128 CCTCGACCAAGAGCTGAAG 64 8 
  R.191 CCTCCAGACCTCACGTTTGTTC   
NM_001304343.1
11 
RXRα F.408 CGCTCCTCAGGCAAGCA 121 11 
  R.506 TGTCAATCAGGCAGTCCTTGTT  
NM_001083640.1 RXRβ F.1232 CGTGGGAGCCATCTTCGA 60 11 




NM_201527.2 SOD2 F.272 GAGAAGGGTGATGTTACAGCTCAGA 100 2 
  R.371 GGCTCAGATTTGTCCAGAAGATG   
NM_174197.2 TLR2 F.88 TGGGTGGAGAACCTCATGGT 100 7 
  R.187 CGATAATCCACTTGCCAGGAA   
NM_174198.6 TLR4 F.85 TGCGTACAGGTTGTTCCTAACATT 110 7 
  R.194 TAGTTAAAGCTCAGGTCCAGCATCT   
NM_173966.3 TNFA F.174 CCAGAGGGAAGAGCAGTCCC 114 7 
  R.287 TCGGCTACAACGTGGGCTAC   
1Coyne, G. S., D. A. Kenny, S. Childs, J. M. Sreenan, and S. M. Waters. 2008. Dietary n-3 
polyunsaturated fatty acids alter the expression of genes involved in prostaglandin biosynthesis in 
the bovine uterus. Theriogenology 70:772–782. 
 
2Garcia, M., T. Elsasser, D. Biswas, and K. M. Moyes. 2014. The effect of citrus-derived oil on 
bovine blood neutrophil function and gene expression in vitro. J. Dairy Sci. 98:918-926.  
 
3Greger, D. L., C. Philipona, and J. W. Blum. 2006. Ontogeny of mRNA abundance of nuclear 
receptors and nuclear receptor target genes in young cattle. Domest. Anim. Endocrinol. 31:76–87. 
 
4Herzog, K., Strüve, K., Kastelic, J.P., Piechotta, M., Ulbrich, S.E., Pfarrer, C., Shirasuna, K., 
Shimizu, T., Miyamoto, A. and Bollwein, H., 2012. Escherichia coli lipopolysaccharide 
administration transiently suppresses luteal structure and function in diestrous 
cows. Reproduction. 144 :467-476. 
 
5Kadegowda, A. K. G., M. Bionaz, B. Thering, L. S. Piperova, R. A. Erdman, and J. J. Loor. 
2009. Identification of internal control genes for quantitative polymerase chain reaction in 
mammary tissue of lactating cows receiving lipid supplements. J. Dairy Sci. 92:2007-2019. 
 
6Krania, F., Dovolou E, Rekkas CA, Heras S, Pappas I, Soom AV, Amiridis GS. 2015. 
Urokinase-type plasminogen activator does not affect in vitro bovine embryo development and 
quality. Acta. Vet. Hungarica. 63:243-54. 
 
7Moyes, K. M., J. K. Drackley, D. E. Morin, M. Bionaz, S. L. Rodriguez-Zas, R. E. Everts, H. A. 
Lewin, and J. J. Loor. 2009. Gene network and pathway analysis of bovine mammary tissue 
challenged with Streptococcus uberis reveals induction of cell proliferation and inhibition of 
PPAR-gamma signaling as potential mechanism for the negative relationships between immune 
response and lipid metabolism. BMC. Genomics 10:542. 
 
8Moyes, K. M., J. K. Drackley, D. E. Morin, and J. J. Loor. 2010. Greater expression of TLR2, 
TLR4, and IL6 due to negative energy balance is associated with lower expression of HLA-DRA 
and HLA-A in bovine blood neutrophils after intramammary mastitis challenge with 
Streptococcus uberis. Funct. Integr. BMC. Genomics. 10:53–61. 
 
9Moyes, K. M., D. E. Graugnard, M. J. Khan, M. Mukesh, and J. J. Loor. 2014. Postpartal 
immunometabolic gene network expression and function in blood neutrophils are altered in 
response to prepartal energy intake and postpartal intramammary inflammatory challenge. J. 
Dairy Sci. 97:2165-2177. 
 
10Naeem, A., J. K. Drackley, J. Stamey, and J. J. Loor. 2012. Role of metabolic and cellular 
proliferation genes in ruminal development is response to enhanced plane of nutrition in neonatal 




11Schmitt, E., M. A. Ballou, M. N. Correa, E. J. DePeters, J. K. Drackley, and J. J. Loor. 2011. 
Dietary lipid during the transition period to manipulate subcutaneous adipose tissue peroxisome 
proliferator-activated receptor,co-regulator and target gene expression. J. Dairy Sci. 94:5913–
5925. 
 
12Seo, J., J.S. Osorio, J.J. Loor. 2013. Purinergic signaling gene network expression in bovine 
polymorphonuclear neutrophils during the peripartal period. J. Dairy Sci., 96: 7675-7683 
 
13Shu, D., A. Heiser, D. N. Wedlock, D. Luo, G. W. de Lisle GW, and B. M. Buddle. 2014. 
Comparison of gene expression of immune mediators in lung and pulmonary lymph node 








































Supplemental Table S4.2. Gene symbol, gene name, and description of the main biological 
functions and processes of targets analyzed in circulating bovine neutrophils. 
Symbol Name 
    Summary description from GENECARDS 
    (www.genecards.org)  
CASP3 Caspase 3 This gene encodes a protein which is a member of the 
cysteine-aspartic acid protease (caspase) family. Sequential 
activation of caspases plays a central role in the execution-





Prostaglandin-endoperoxide synthase (PTGS), also known 
as cyclooxygenase, is the key enzyme in prostaglandin 
biosynthesis. This gene encodes the inducible isozyme. It is 
regulated by specific stimulatory events, suggesting that it 






This gene encodes a member of the glyceraldehyde-3-
phosphate dehydrogenase protein family. It is expressed 
stable in PMN, therefore served as one of the housekeeping 
genes in PMN 
 
IL6 Interleukin 6 This gene encodes a cytokine that functions in 
inflammation and the maturation of immune cells. In 
addition, the encoded protein has been shown to be an 
endogenous pyrogen capable of inducing fever in animals 
with autoimmune diseases or infections 
 
IL10 Interleukin 10 The protein encoded by this gene is produced by 
neutrophils). IL-10 can block NF-kappa B activity as the 
role of anti-inflammatory cytokines. 
 
ITGB2 Integrin Subunit 
Beta 2 
Integrins are integral cell-surface proteins that participate 
in cell adhesion as well as cell-surface mediated signaling. 
The encoded protein plays an important role in the immune 
response. 
  
mTOR Mechanistic target 
of rapamycin 
The protein encoded by this gene belongs to a family of 






This gene encodes a cytosolic adapter protein that plays a 
central role in the innate and adaptive immune response. 
This protein functions as an essential signal transducer in 
the interleukin-1 and Toll-like receptor signaling pathways. 
 
NCF1 Neutrophil 
cytosolic factor 1 
The protein encoded by this gene is a 47 kDa cytosolic 
subunit of neutrophil NADPH oxidase. This oxidase is a 







cytosolic factor 2 
This gene encodes neutrophil cytosolic factor 2, the 67-
kDa cytosolic subunit of the multi-protein NADPH oxidase 
complex found in neutrophils. This oxidase produces a 
burst of superoxide. 
 
NFKB1 Nuclear factor 
kappa B subunit 1 
This gene encodes for a DNA binding subunit of the NF-
kappa-B (NFKB) protein complex. NFKB is a transcription 
regulator that is activated by various intra- and extra-
cellular stimuli such as cytokines, oxidant-free radicals, 
ultraviolet irradiation, and bacterial or viral products. 
 
NOS2 Nitric oxide 
synthase 2 
This gene encodes a nitric oxide synthase which is 
expressed in neutrophil and is inducible by a combination 






This gene encodes the receptor for urokinase plasminogen 
activator and, given its role in localizing and promoting 
plasmin formation, likely influences many normal and 
pathological processes related to cell-surface plasminogen 







The action of peroxisome proliferators is thought to be 
mediated via specific receptors, called PPARs, which 
belong to the steroid hormone receptor superfamily. 
PPARs affect the expression of target genes involved in 
cell proliferation, cell differentiation and in immune 
responses. This gene encodes the sub-type PPARα, which 
is a nuclear transcription factor.  
 
RARα Retinoic acid 
receptor alpha  
This gene represents a nuclear retinoic acid receptor. The 
encoded protein, retinoic acid receptor alpha, regulates the 
transcription in a ligand-dependent manner. 
 
RPS9 Ribosomal Protein 
S9 
This gene encodes a ribosomal protein that is a component 
of the 40S subunit. It served as one of the housekeeping 
genes in PMN 
 
RXRα Retinoid X 
receptor  
alpha 
Retinoid X receptors (RXRs) and retinoic acid receptors 
(RARs) are nuclear receptors that mediate the biological 
effects of retinoids by their involvement in retinoic acid-
mediated gene activation.  
 
 
RXRβ Retinoid X 
receptor beta 
This gene encodes a member of the RXR family of nuclear 
receptors which are involved in mediating the effects of 
retinoids .  
SELL L-Selectin Belongs to a family of adhesion/homing receptors. The 




of leukocytes on endothelial cells, facilitating their 
migration into secondary lymphoid organs and 





Member of the superoxide dismutase family; binds to the 
superoxide by-products of oxidative phosphorylation and 
converts them to hydrogen peroxide and diatomic oxygen.  
 
TLR2 Toll-like receptor 2  
 
They recognize pathogen-associated molecular patterns 
(PAMP) that are expressed on infectious agents, and 
mediate the production of cytokines necessary for the 
development of effective immunity. This gene is expressed 
most abundantly in peripheral blood leukocytes, and 
mediates host response to Gram-positive and negative 
bacteria and yeast via stimulation of NFKB.  
 
TLR4 Toll-like receptor 
4  
 
This receptor has been implicated in signal transduction 
events (innate immunofunctions) induced by bacterial 
lipopolysaccharide (LPS) a PAMP found in most gram-
negative bacteria. 
 
TNFA Tumor necrosis 
factor alpha  
 
This gene encodes for the multifunctional proinflammatory 
cytokine mainly secreted by macrophages; involved in cell 
proliferation, differentiation, apoptosis, lipid metabolism, 
and coagulation. This cytokine has been implicated in a 
variety of diseases, including autoimmune diseases, insulin 






















Supplemental Table S4.3: Efficiency of dilution curves and median Cq values for all tested 
samples. 
  Dilution curve1   Cq Values across all samples5 








CASP3 -3.228 0.996 1.04 28.28 31.92 29.52 
COX2(PTGS2) -3.328 0.999 1.00 23.70 28.49 26.37 
GAPDH -3.417 0.998 0.96 23.84 28.08 24.99 
IL6 -3.464 0.999 0.94 25.58 28.73 26.97 
IL10 -3.150 1.000 1.08 26.32 29.60 27.57 
ITGB2 -3.525 0.995 0.92 27.09 30.85 28.30 
mTOR -4.345 0.999 0.70 30.42 35.37 32.35 
MYD88 -3.148 0.999 1.00 26.44 30.41 34.48 
NCF1 -3.175 0.995 1.07 23.50 27.90 24.37 
NCF2 -3.102 0.998 1.10 27.34 31.59 29.04 
NFKB1 -3.410 0.998 0.96 24.69 28.27 26.20 
NOS2 -3.128 0.998 1.09 27.98 31.61 29.86 
OSBPL2 -3.398 1.000 0.97 27.38 31.28 28.44 
PLAUR -3.480 0.999 0.94 24.26 27.91 25.76 
PPARα -3.583   0.998       0.90 32.22 36.39 34.48 
RARα -3.454 0.999 0.95 25.39 29.58 26.71 
RPS9 -3.481 0.997 0.94 23.54 28.37 25.66 
RXRα -2.952 0.996 1.18 26.88 30.21 28.18 
RXRβ -3.188 0.999 1.06 27.99 32.84 29.76 
SELL -3.294 0.999 1.01 24.29 28.36 25.66 
SOD2 -3.345 0.998 0.99 21.46 25.81 23.06 
TLR2 -3.544 0.997 0.91 24.77 28.58 26.80 
TLR4 -3.218 0.997 1.05 25.77 29.73 26.79 
TNFA -3.167 0.995 1.07 24.12 29.21 26.17 
1 Efficiency was tested with 6 serial dilutions (1:4) 
2 Slope of the dilution curve 
3 Coefficient of determination of the dilution curve 
4 Efficiency of the dilution curve was calculated as [(10(-1 / Slope))-1] 
5 Cq values corresponding to all analyzed samples for each corresponding gene using 4 µL of 











   
 
 
Supplemental Figure S2.1 Tocopherol isoform concentration in bovine mammary mitochondria: 
Control vs. Tmix (mixed tocopherol oil supplement) feeding groups after 9 d feeding for either α-
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